healthcare market research australia

• Face-to-Face
• Qualitative Recruitment
• Mystery Shopping
• Bespoke Studies

Telephone Interviewing - we hear you

Live Phone Polling

We are public and political opinion polling data collection experts

A variety of data collection techniques to suit your needs

Dedicated specialist healthcare research division of TKW Research

Consumer market research recruitment specialists

Keep your customers coming back for more with unrivalled insights that will empower exceptional customer experiences

Where others see complexity, we see opportunity

• Privacy & Quality Compliance

Incorporating many well-known market research data collection brands, TKW Research Group is now one of the largest market research field agencies in Australia and New Zealand.

A strong, passionate team makes a company, come and meet ours!

Our commitments to our clients and our interviewees.

• Knowledge Box

TKW Health is the dedicated specialist healthcare research division of TKW Research Group.

Our Database

Our Approach

Qualitative research.

Quality respondents for your Qualitative study

Transcripts & Content Analysis

Focus groups, in-depth interviews, quantitative research.

We offer a plethora of quantitative studies to suit your goals

Patient Studies

Scripting / hosting, healthcare database, we reach the audience you need – provide us the specs and we’ll do the rest.

• Dedicated healthcare leadership team with decades of medical market research experience.
• A deep understanding of the special needs within the medical community.
• Expertise in global studies providing access to the Australian and New Zealand markets.
• The ability to recognise the difficulties involved in getting hold of the right doctor or specialist and tailor strategies to maximise response rates.
• Expertise in presenting sensitive topics.
• Highly knowledgeable in all methods of qualitative and quantitative research.
• Mixed methodology recruitment experience; we are able to recruit samples from your own lists, our own database, social media, cold calling and advertising.
• 360 degree support collaborating with you from set up, through to fieldwork and the delivery of the final data.
• Skilled data scientists to analyse the data and put together a comprehensive report of the findings.
• We can manage the entire project including organising all required elements; scripting, expert moderators, venues, interviewers, products, diaries and incentives.

Who we work with

With a portfolio of clients in the pharmaceutical, Government, medical devise, market entry, local SMEs and patient satisfaction space we have built up a reputation as industry leaders by focusing on a deeper understanding of the healthcare industry through our range of solutions.

With specialised teams in both qualitative and quantitative healthcare market research, TKW Health is your premium partner.

What our clients say about us

“Zoos Victoria have been working with TKW Research Group for seven years. They have been excellent in pinpointing our strengths and weaknesses in the Admissions and Retail areas of our business. Their unbiased mystery shopping results have enabled us to continually improve our sales and visitor experience front-line teams. Their service is always professional and prompt and I highly recommend using TKW Research Group for your mystery shopping research.”

Eamonn Verberne

Zoos Victoria

Associations and Accreditation

Australia’s #1 Most Trusted Healthcare Data Collection & Recruitment Agency

A leading Australian healthcare market research agency

Optimising the balance between scientific rigour and practical simplicity, we deliver superior insights and solutions to the Australian healthcare industry.

WE HAVE A WINNER! Congratulations Dr JH from Qld. Thank you to all who entered in our Hummingbird Advisory panel $700 prize draw.

Hummingbird Advisory is a market research panel owned and operated by Hummingbird Insight Pty Ltd.

Hummingbird Insight is an Australian healthcare market research agency specialised in the healthcare sector. Optimising the balance between scientific rigour and practical simplicity, we deliver superior insights and solutions to the Australian healthcare industry.

Our Hummingbird Advisory panel platform enables us to connect with professional healthcare providers to participate in our market research studies.

The Hummingbird Advisory panel allows us to tailor our research approach to your specific medical interests and expertise. In doing so, we can gather the valued medical opinions of healthcare professionals like yourself ranging from medical specialists to GPs, nurses, pharmacists, and other ancillary healthcare professionals, on a range of medical conditions, healthcare products, services, and technologies that is of special interest to them and our healthcare clients.

HOW IT WORKS

What’s in it for you.

Our Hummingbird Advisory panel platform offers you an opportunity to provide feedback and be paid for your valued opinions. All together, we can continually improve the healthcare industry in Australia.

You can participate in our market research studies, learning more about current healthcare products, services, and technologies, and new developments coming onto the Australian market.

REWARDED FOR YOUR TIME

Hummingbird Advisory offers generous remunerations paid to participants based on full completion of all tasks required and takes into consideration our clients’ needs, the degree of dificulty, time, and medical expertise matching the criteria.

Our email invitations will state the specific remuneration, paid via electronic funds transfer. Payments are issued once the research study has been completed.

PARTICIPATE IN PROJECTS

We will email you an invitation to participate in a market research study suitable to your medical expertise. You simply click on the link provided in the email to answer some initial qualifying questions, then follow the prompts to complete the remaining questions if you qualify.

Some of our market research studies are simple online surveys, others require a ZOOM interview with a researcher using your laptop/PC. Each study has different qualifying criteria, so please don’t be disheartened if you don’t qualify for one study, as we are constantly conducting market research projects and one will be more suitable to your medical expertise.

Also, we appreciate that you may be very busy with your patients, so we don’t expect that you will be able to respond to all our emails. However, we may contact you to follow up if we feel your medical profile is suited to a particular study. Of course, you can unsubscribe any time to remove yourself from our Hummingbird Advisory panel.

THE COMMUNITY

Essentially, you only need to register your contact details once on Hummingbird Advisory. You will be allocated a unique ID and password for your future access to your profile.

Our experienced panel staff may need to contact you to follow up on your special medical interests or other appropriate criteria that will assist us in the selection criteria for our market research studies.

If you are already registered, you can simply log in to update your contact details when required.

METIS HEALTHCARE RESEARCH

HEALTHCARE RESEARCH

Metis: the embodiment of “prudence”, "wisdom" or "wise counsel" of exercising sound judgement in practical affairs..

METIS was founded in July 2011 by people who are passionate about pharmaceutical marketing research.

We offer a unique combination of Australia’s most experienced and accomplished healthcare marketing researchers.

We thrive on the unique and complex challenges that impact the marketing of pharmaceutical and healthcare products and services.

Our enthusiasm, longstanding experience, research skills and understanding of healthcare markets in Australia places us in a unique position to address client’s research needs within the intricate arenas in which they operate.

THE EXPERIENCE

The list below outlines the therapy areas for which we have completed projects over the last 5 years

Acne Acute coronary syndrome ADHD aHUS Allergic rhinitis Anaesthesia Antiplatelets Asthma Atrial fibrillation Basal cell carcinoma BPH Bipolar disorder Breast cancer Cancer pain Chronic pain CML CMV infection COAD / COPD Colorectal cancer Constipation

Cough Crohn's disease Dermatitis DVT prevention Epilepsy Fertility treatment Gastric cancer GI upset Gaucher's disease Glaucoma Glioblastoma Heart failure Hepatitis C HIV Hospital acquired infections HPV HRT Hypertension​

Incontinence Invasive fungal infections Irritable bowel syndrome ITI Melanoma Menopause Multiple sclerosis Natural medicines Non-Hodgkin's Lymphoma Non small cell lung cancer Non-prescription analgesics Opiod dependence Osteoarthritis Osteoporosis Ovarian cancer Parkinson's disease PHN Post operative pain Prostate cancer

Pulmonary arterial hypertension Reflux / GORD Renal anemia Rheumatoid arthritis Schizophrenia Secondary stroke prevention Skin cancer Sleep disorders Sleep apnoea Transplantation Type 1 diabetes Type 2 diabetes Vaccines Varicose veins​

METIS LEADERS IN HEALTHCARE RESEARCH

Simon greenland.

Over the last 21 years, Simon has held roles at Millward Brown Australia, Robinson & James Research and IMS Health. For the last 14 years he has specialised in healthcare marketing research. Prior to establishing METIS Healthcare Research, Simon, was Principal of the Market Research division at IMS Health. Previously he was a Director of Robinson & James Research, which was one of Australia’s longest standing and leading healthcare marketing research companies. Simon has extensive experience in a wide range of therapeutic areas and across a wide variety of methodologies, and is recognised as one of Australia’s leading healthcare market researchers.

Richard James

As one of Australia’s most experienced pharmaceutical marketing researchers, with over 20 years of experience, Richard has been responsible for both qualitative and quantitative marketing research projects across a wide range of healthcare professional groups and indications. Prior to starting METIS Healthcare, Richard was responsible for managing the marketing research team at IMS Health. Prior to joining IMS in February 2008, Richard was Founding Director of Robinson & James Research (started in 1992) – which was one of Australia’s longest standing and leading healthcare marketing research companies. IMS Health acquired Robinson & James Research in 2008.​

SALLY HOGBIN

Over the last 15 years, Sally has refined her experience in pharmaceutical market research through her roles at Foresearch, Robinson & James Research and IMS Health. Prior to starting METIS Healthcare, Sally was a Senior Consultant - Primary Marketing Research at IMS Health. Previously she was a Research Director at Robinson & James Research, which was one of Australia’s leading healthcare marketing research companies. Sally joined Robinson & James Research after a successful period at Foresearch – another dedicated healthcare research company – which followed her initial career in consumer marketing research at Millward Brown.

+612 9135 2957 100 WALKER ST NORTH SYDNEY NSW 2060

100 walker st,north sydney nsw 2060.

Australia Health Services Research

• Veterinary Equipment
• Animal Drugs
• Animal Vaccines
• Purified Proteins
• Bioservices
• Biotechnology Research Equipment
• Protein Engineering
• Electro Therapy
• Nuclear Medicine
• Cardiovascular
• Dental Care
• Diabetes Care
• Ophthalmology
• Pulmonology
• Drug Filled Devices With Needle
• Clinical IT
• Healthcare Analytics
• Aesthetic Devices
• Clinical Diagnostic Instrument
• Immune System Diagnostics
• Infectious Disease Testing
• Handheld Monitoring Devices
• Single time Monitoring Devices
• Molecular Diagnostic Devices
• Medical Optical Imaging
• Nuclear Medicine Imaging
• Fluoroscopy
• Mammography
• Surgical Imaging
• Joint Reconstruction
• Drug Delivery Products
• Personal Protective Equipment
• Dental Medical Instruments
• Hospital and Clinical Use
• Ablation Devices
• General Surgical Devices
• Minimally Invasive Surgery Devices
• Bariatric Surgery Devices
• Surgical Access Devices
• Wound Care Devices
• Contraceptive Devices
• Anesthesia Equipment
• Insulin Pumps
• Hyperglycemics
• Behavioural Disorder Drugs
• Diabetes Care Drugs
• Oncology Drugs
• Developmental Anomalities
• External Condition Drugs
• Immune System Drugs
• Infectious Disease Drugs
• OB/GYN Drugs

Filter Reports

50 Australia Health Services Reports

Country Covered: Australia

Study Period: 2021 - 2029

Major Players: 3D Systems, Canadian Aviation Electronics (CAE) Inc., Kyoto Kagaku Co. Ltd, Laerdal Medical, Limbs & Things Ltd

Study Period: 2019 - 2029

Major Players: Biomedical Waste Solutions, LLC, Clean Harbors, Inc., Daniels Sharpsmart Inc., Stericycle, Inc., Waste Management, Inc.

Major Players: Medical Facilities Corporation, SHERIDAN HEALTHCARE, Surgery Partners, Aspen Healthcare, NueHealth

Major Players: Healthbase, Apollo Hospitals, KPJ Healthcare, Klinikum Medical Link, Medretreat

Major Players: Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc, Siemens Healthineers

Major Players: 3D Systems Inc., CAE Inc., Gaumard Scientific Company Inc., Laerdal Medical, Kyoto Kagaku Co. Ltd

Major Players: Agilent Technologies Inc., Bio-Rad Laboratories Inc., Illumina, Merck Millipore (Merck KGaA, Danaher Corporation

Major Players: ABM Industries Inc., Aramark Corporation, Ecolab Inc., Sodexo, Iss World Services A/S

Major Players: Acadia Healthcare, Behavioral Health Group (BHG), Aurora Behavioral Health System, Promises Behavioral Health, AAC Holdings Inc.

Major Players: Eurofins Scientific, Institute for Testing and Certification Inc., BSI Group, SGS SA, Intertek Group PLC

Major Players: Alberta Health Services, Alliance HealthCare Services, Alliance Medical, Campbell County Healt, Netcare Hospita

Major Players: Accountable Healthcare Staffing, Cross Country Healthcare, HealthTrust Workforce Solutions (HCA), Maxim Healthcare Services, AMN Healthcare

Major Players: OPKO Health Inc., Quest Diagnostics Incorporated, LabCorp, NeoGenomics, Myriad Genetics, Inc.

Major Players: GE Healthcare, Koninklijke Philips N.V., Omron Corporation, Core Health & Fitness, LLC, Technogym

Major Players: Bio-Rad Laboratories, Inc.,, FAPAS, LGC Limited, Merck KGaA, Trilogy Analytical Laboratory

Major Players: Merz Pharma, INNOVATIVE SKINCARE, Obagi Cosmeceuticals LLC, SkinCeuticals International, Abbvie Inc (Allergan PLC)

Major Players: BioMedical Waste Solutions, LLC, Clean Harbors, Inc., Sharps Compliance, Inc., US Ecology, Inc., Waste Management, Inc.

Major Players: Envision Healthcare Corporation, Falck Holding A/S, Acadian Ambulance Service, Inc., Ziqitza Health Care Limited, Medivic Aviation

Major Players: St Joseph's Health Care London, NextCare Holdings, Inc., Select Medical Holdings (Concentra, Inc.), UnitedHealth Group (MedExpress ), HCA Healthcare(HCA Healthcare UK)

Major Players: Charles River, Labor Dr. Merk & Kollegen GmbH, Merck KGaA, Texcell, WuXi AppTec

Major Players: Abbott, Thermo Fisher Scientific, LabCorp, Healgen Scientific LLC, Premier Biotech, Inc.

Major Players: Wellness Corporate Solutions, LLC, EXOS, ComPsych Corporation , Virgin Pulse Inc. , Quest Diagnostics Incorporated

Major Players: Fresenius SE & Co KGaA, F. Hoffmann-La Roche AG, Apple Inc, Resmed Inc, Amwell

Major Players: Paraxel International , IQVIA Inc, Laboratory Corporation of America Holdings, Icon Plc, Cardinal Health

Major Players: Grifols S.A. , Immucor Inc. , Thermo Fisher Scientific , Merck KGaA , Abbott Laboratories

Major Players: Genpact Ltd , IQVIA Holdings Inc , Certara, L.P. , Pharmaceutical Product Development, LLC (PPD) , Charles River Laboratories International, Inc

Major Players: Illumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd

Major Players: Brookdale Senior Living, Inc. , Extendicare, Inc., Sunrise Senior Living, Atria Senior Living, Inc., Sonida Senior Living

Major Players: Genesis Healthcare Corporation, VITAS Healthcare, Sunrise Senior Living LLC (Revera), Amedisys, Lifepoint Health, Inc (Kindred Healthcare)

Major Players: Biotrial , Clario, Ncardia AG, Banook Group, Koninklijke Philips N.V.(BioTelemetry)

Please be sure to check your spam folder too.

Get a free sample of this report

Please enter your name

Business Email

Please enter a valid email

Please enter your phone number

Sorry! Payment Failed. Please check with your bank for further details.

Want to use this image? X

Please copy & paste this embed code onto your site:

Images must be attributed to Mordor Intelligence. Learn more

About The Embed Code X

Mordor Intelligence's images may only be used with attribution back to Mordor Intelligence. Using the Mordor Intelligence's embed code renders the image with an attribution line that satisfies this requirement.

In addition, by using the embed code, you reduce the load on your web server, because the image will be hosted on the same worldwide content delivery network Mordor Intelligence uses instead of your web server.

Contact an Austrade specialist as an investor as a buyer

Health and life sciences

State ecosystems

Australia’s fast-growing life sciences sector is one of the largest in the southern hemisphere. It’s worth more than $250 billion and home to more than 2,600 organisations. Our high-quality and innovative healthcare system is envied around the world. It’s underpinned by a world-class medical research sector, nurtured in our universities and hospitals, medical research institutes and life science companies.

Thinking about entering the Australian market?

• Investors typically establish a new company, register as a foreign company or acquire an existing company. Assess your options with our Investor Guide .
• Austrade is Australia’s national investment promotion agency. We attract and facilitate game-changing foreign direct investment into Australia. Our team of business and investment specialists can connect investors to early-stage opportunities in Australia and provide direct and tailored professional assistance. Find out how we can help .

Australia’s progressive environment fosters research translation, manufacturing and clinical adoption with ease. Businesses considering expanding to Australia will find:

• An established and early-adopting healthcare system
• A vibrant innovation ecosystem with world-class medical research expertise and infrastructure.
• Outstanding clinical trial capabilities, with streamlined and globally-recognised regulatory pathways to expedite studies.
• Significant government support, including an R&D tax offset of up to 43.5% and more than A$21.5 billion in support funds for life sciences.
• An export-driven economy with 18 free trade agreements
• Strong intellectual property protections

Advanced Therapeutics in Australia 2023

Australia has full bench to bedside capabilities. Find out why Australia is an outstanding location to research, develop and scale your life sciences innovations.

Source: AusBiotech Snapshot 2022

A culture of innovation

Australia has a strong culture of innovation and investment in medical research. It makes us a key development hub for cutting-edge medical procedures and life-saving medicines.

We consistently rank among Nature Index’s top 10 contributors to life sciences research globally – including ninth in 2022 .

World-leading medical research institutes are found across the country, including the Walter and Eliza Hall Institute in Melbourne, Queensland’s Translational Research Institute , the South Australia Health and Medical Research Institute , the Harry Perkins Institute of Medical Research in Perth and the Garvan Institute of Medical Research in Sydney.

Our world-class universities top the leaderboards in multiple health and medical research fields, such as oncology, neurology, regenerative medicine, medical devices, tropical diseases, diabetes, cardiovascular disease and diagnostics.

Collaborating with an Australian university provides access to some of the world's best minds. The Australian government is investing in university-industry partnerships through the A$2.2 billion University Research Commercialisation Package .

Top Australian innovations

With a history of Nobel Prize-winning research, Australia has made significant contributions to global medical science: 

• GARDASIL® – the HPV vaccine that is significantly lowering the risk of HPV-related cancers for women and men around the world
• Electronic pacemaker
• Ultrasound for pregnancy
• Bionic ear – the cochlear implant is one of the earliest examples of improving wellbeing through digital technology
• Spray-on skin
• Prevention of spina bifida with folate
• Penthrox® inhaler (green whistle) – a pain relief inhaler used in trauma and emergency settings
• CPAP – a successful, non-invasive breathing support device – invented in 1981 and used by patients during the COVID-19 pandemic
• EVestG – a diagnostic tool that detects mental and neurological illnesses. 
• Australia ranks 3rd among high-income countries for healthcare choice and fifth for quality (Source: 2022 FREOPP World Index of Healthcare Innovation )
• We’re 2nd among OECD countries for health (Source: OECD Better Life Index )
• Australia spends US$176 billion on health - the 6th highest health expenditure in the world. (Source: Fitch Solutions Group, Worldwide medical devices market factbook 2022 )
• Australia is a “go-to” clinical trial destination, with the world’s 3rd highest rate of industry-initiated early phase clinical trials (Source: ABPI 2022 )
• 11% of global cell and gene therapies clinical trials were conducted in Australia (Source: AusBiotech 2021 )
• More than four in five Australians support patients’ medical records being used for research ( Research Australia 2020 ). More than nine in ten would share their de-identified personal health information to advance medical research, support patient care, develop new diagnostics or treatments or track diseases ( Research Australia 2021 )
• Australia ranks 3rd for intellectual property rights on the International Property Rights Index 2022

Our vibrant industries

Aged care is a growing industry in Australia. The Australian population is ageing rapidly: by 2066, it’s estimated that 22% of the Australian population will be aged 65 years or over ( Australian Bureau of Statistics, 2018 ). The Australian Government is forecast to spend A$36 billion nationwide in 2023-24 .

The Australian biotech sector has grown by 40% in the last two years. It’s valued at almost A$250 billion market capitalisation (Source: Stockhead 2022). With the establishment of a new Moderna mRNA vaccine manufacturing facility in Victoria further expanding Australia's vaccine manufacturing capability, the sector is expected to generate over A$8 billion in gross value added and $12 billion in manufacturing exports. With a vibrant research ecosystem and established clinical trials sector, there is significant demand that are creating opportunities for new investment into Australia.

Clinical Trials

Australia’s clinical trial capabilities, skilled workforce and specialised infrastructure are second to none. Our globally recognised regulator, the Therapeutic Goods Administration (TGA), provides fast-track regulatory pathways. Quality data from Australian studies can be used to support international submissions, including to the US Food and Drug Administration (FDA) and European Medicines Agency (EMA).

Digital Health

Australia is at the forefront of adopting innovative digital health technologies such as telehealth, electronic patient records and wearable devices. This is partly due to the development of connected national health infrastructure. It’s supported by multi-billion-dollar government investments and initiatives to establish data standards and drive interoperability.

Our health consumer ecosystems, market dynamics and regulatory frameworks are similar to the US and EU. It makes us an ideal location to pilot new digital health solutions before scaling to global markets.

The total market for medical devices in Australia is valued over US$4.9 billion (Source: Medical Technology Association of Australia 2021/22 ). Australia’s strengths include bionic devices; implantables; nanotechnology; wearable devices; digital smart devices; digital therapeutics and 3D-printed body parts. Australia provides a low-risk testbed to develop and test medtech products, with quality clinical trials data accepted in other major markets.

Grants, incentives and support

• the A$450 million  , which supports innovative early-stage health and medical research in Australia.
• the A$47 million MRFF  Targeted Translation Research Accelerator , which is improving the prevention and treatment of diabetes and cardiovascular disease.
• The  Clinical Trials Activity  initiative. This will provide $750 million over 10 years from 2022–23 to help Australian researchers and patients test new treatments through national and international clinical trials.
• A new A$50 million Australian Government-funded incubator program is due to launch in 2023, providing grants of up to $5 million for emerging biomedical and digital health companies. The new BioMedTech Incubator (BMTI) program will be jointly delivered by venture firm Brandon Capital’s BioCatalyst program and digital health accelerator ANDHealth.
• The National Reconstruction Fund (NRF) has A$1.5 billion earmarked for medical manufacturing through co-investment by the Australian Government via debt or equity support or guarantees.
• The  Biomedical Translation Fund  is A$501 million co-investment program helping translate biomedical discoveries into products and services.
• The  Research and Development Tax Incentive   makes Australia globally competitive for companies looking to innovate. Companies can access an R&D tax offset of up to 43.5% for eligible R&D expenditure greater than A$20,000.
• MTPConnect is an independent Australia Government-supported industry growth centre that for the medtech, biotech and pharmaceutical sectors.
• The  National Health and Medical Research Council  supports investigator-led research activities across all areas of health and medicine, providing grants in excess of A$850 million a year.
• The  Australian Research Council  funds fundamental and applied research across a broad range of health and medical science fields.
• AusBiotech has launched a directory of accelerators and incubators relevant to Australian life sciences companies in the early stages of their development. The majority of programmes listed provide funding.
• Australia boasts a number of  health precincts that connect hospitals, universities, research institutes and industry partners support collaboration and knowledge transfer such as the QEII Medical Centre and Adelaide BioMed City .

Life science capability map

Explore Australia’s capabilities and innovation in the life sciences sector.

Australia’s national science agency, CSIRO, is one of the world's largest mission-driven multidisciplinary science and research organisations.

CSIRO consistently ranks in the top 1% of the world’s scientific institutions in 15 of 22 research fields (CSIRO Annual Report 2021-22 ).

Its expertise includes molecular diagnostic solutions and precision health and medicine research. Facilities include:

• National Vaccine and Therapeutics Lab 
• Recombinant Protein Production and Purification Facility  
• Australian Centre for Disease Preparedness  
• Biomedical Materials Translational Facility  

Success stories

SK bioscience partners with Vaxxas on needle-free typhoid vaccine

SK bioscience is partnering with Australian biotech company Vaxxas to develop a needle-free, second-generation typhoid vaccine. The partnership is supported by a US$3.67 million grant from global charitable foundation Wellcome. 

Under the partnership agreement, SK bioscience will supply the antigen used by its typhoid conjugate vaccine, SKYTyphoid™. The vaccine was developed by SK bioscience and the International Vaccine Institute, with funding support from the Bill and Melinda Gates Foundation. 

Vaxxas will reformulate the antigen so it can be “printed” onto its high-density microarray patch (HD-MAP) technology. The technology uses a patch with thousands of vaccine-coated micro-projections. The patch is applied to the skin for a few seconds to deliver the vaccine to the immune cells immediately below the skin’s surface.  

The antigen will also be reformulated to be more stable at high temperatures than required for needle and syringe vaccination. The vaccines could then be potentially stored and distributed at room temperature, making them more accessible to lower- and middle-income countries with limited cold-chain distribution infrastructure. 

Vaxxas will conduct preclinical studies on the reformulated vaccine. If successful, the studies will be followed by a Phase I human clinical trial. The project is expected to be completed within two years from initiation to reporting the data from the Phase I clinical trial. 

Fighting influenza with the Doherty Institute 

SK bioscience has also signed a research collaboration agreement with the Peter Doherty Institute for Infection and Immunity ( Doherty Institute ) in Melbourne, Australia. 

The agreement will include: 

testing anti-influenza compounds to identify new antivirals  

capacity building in low- and middle-income countries of the region  

developing a new influenza vaccine platform. 

The Doherty Institute is one of seven  WHO Collaborating Centres for Reference and Research Influenza  (WHOCCRRI). The Doherty Institute has more than 700 staff who work on infection and immunity through a broad spectrum of activities. This includes discovery research; diagnosis, surveillance and investigation of infectious disease outbreaks; and the development of ways to prevent, treat and eliminate infectious diseases. 

Australia’s healthcare system is underpinned by a world-class medical research sector, nurtured in our universities and hospitals, medical research institutes and life science companies. Find out more about Australia’s thriving health and life sciences sector.  

How Austrade helped  

Austrade will continue to provide SK bioscience with insights on the Australian life sciences market and introduce the company to collaborative research opportunities. 

Austrade will support international delegates attending the AusBiotech 2023 conference (1–3 November 2023) in Brisbane. The Seoul Bio Hub will host the Korea-themed session on 2 November followed by the Korea night networking event. 

Go further, faster with Austrade 

Contact Austrade for more information about investment opportunities in Australia 

Subscribe to the Investment Update newsletter to find out about new investment opportunities, insights and investor success stories across Australia.

Published: 25 September 2023

Spinogenix to conduct world-first clinical trial in Australia

US biotech company Spinogenix is conducting a world-first clinical trial in Australia. The company is investigating a therapy that could slow the progression of motor neurone disease.

Spinogenix is recruiting 112 participants for the trial, set to begin in 2024. It is seeking healthy volunteers and patients with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s Disease.

Nucleus Network will conduct the trials at its facilities in Melbourne, Victoria. The company is one of Australia’s largest Phase 1 clinical trials organisations. It has conducted over 1,000 trials for global biotechnology and pharmaceutical companies.

‘We are extremely pleased to receive approval from [Australia’s] Human Research Ethics Committee to proceed with human clinical trials,’ says Spinogenix Founder and CEO Dr. Stella Sarraf. ‘These human clinical trials will help us determine safety and tolerability in healthy volunteers. They will also provide early signals of efficacy of our novel, first-in-class drug to help improve the lives of people with ALS.

A new therapy to treat ALS

Founded in 2016, Spinogenix develops transformative therapeutics for diseases involving synaptic loss and dysfunction.

Spinogenix’s SPG302 treatment candidate is designed to increase the number of synapses in nerve cells. Synapses are the key connections between neurons that allow people to think, plan, remember and control motor functions. These faculties are diminished in neurodegenerative diseases like ALS.

In tests on mice, SPG302 was found to slow the progression of symptoms. It was also found to prolong life span by restoring broken neuron connections in the brain.

The current therapies for ALS provide only a modest extension of life and are not well tolerated by all patients. ALS is almost invariably fatal within 3 to 5 years of diagnosis.

A top destination for clinical trials

Australia has more than 50 clinical trial networks offering Phase I – IV clinical trials. Many clinical trial sites are in biomedical precincts close to universities, research institutions and private industry. Australia offers clinical trials for several biologics sub-sectors, including gene therapies, cell therapies, antibody-based therapies, CAR-T therapies and RNA therapies.

Data from clinical trials conducted in Australia is accepted by the US Food and Drug Administration (FDA) and European Medicines Evaluation Agency (EMEA). Australia’s streamlined regulatory approval system reduces the time it takes start clinical trials.

Australia also offers grants and incentives that can help reduce clinical trial costs.

Find out more about Australia’s clinical trials capabilities .

How Austrade helped

Austrade provided Spinogenix with information about Australia’s clinical trials ecosystem and facilitated introductions to local partners. Additionally, Spinogenix participated in Austrade’s Clinical Trials Roadshow in October 2022, which was delivered in partnership with IQVIA, 360 Biolabs, Bentleys and Nucleus Network.

Go further, faster with Austrade

Contact Austrade for more information about investment opportunities in Australia

• Subscribe to the Investment Update newsletter to find out about new investment opportunities, insights and investor success stories across Australia. 

Published: 15 September 2023

Myeloid and NSW Government partner on A$96m manufacturing facility dedicated to RNA immunotherapies

Myeloid Therapeutics is building a state-of-the-art RNA manufacturing and research facility in Australia. The US company is partnering with the New South Wales Government and Macquarie University on the project.

The NSW Government is investing A$96 million in the facility. It will be the only site in Australia and one of a handful in the world where a wide range of RNA therapeutics and potential delivery technologies will be independently produced.

The facility will accelerate the commercialisation of Myeloid’s RNA-based therapeutics and enable the company to secure its supply chain for clinical development. The investment and collaboration will also enhance the growth potential of other biotechnology companies and researchers in Australia.

Speeding the development and commercialisation of RNA therapeutics

Myeloid is a clinical stage mRNA-immunotherapy company. It integrates the fields of RNA, immunology and medicine to develop novel therapies for cancer and autoimmune diseases.

The state-of-the-art RNA manufacturing and research facility will be at the Macquarie University campus in the Connect Macquarie Park Innovation District . The facility will include laboratories and other support spaces to support the development of products evaluated in Australian clinical trials and across the globe.

The facility will leverage NSW’s world-class cell and gene therapy expertise. It will also leverage the NSW RNA Production & Research Network, the UNSW RNA Institute and Australia’s first Viral Vector Manufacturing Facility at the Westmead Health and Innovation District.     Myeloid’s CEO and co-founder Dr. Daniel Getts is an Australian researcher.

‘By enabling control of our manufacturing processes, combined with our proven bioengineering capabilities and mRNA expertise, we have secured a unique, non-dilutive path to delivering our product portfolio to patients,’ he says.

‘We are proud to partner with NSW, who have demonstrated foresight and a willingness to innovate, by deploying capital for the facility and more broadly, for the health benefit of its citizens. We and NSW share the goal to bring innovative, cost-effective immunotherapies to patients who need them in a timely manner and on a consistent basis.’     Find out more about Australia’s thriving health and life sciences sector.

Austrade has supported Myeloid since May 2022. Austrade’s advice and introductions ensured Myeloid secured the best location and partners for its investment.

Austrade has:

introduced Myeloid to Australian state governments to discuss opportunities

invited Myeloid to various conferences and industry events where the company could meet Australian industry and build its network

facilitated meetings with potential partners including medical research institutes and pharmaceutical companies

arranged introductions to potential co-investors and financial sector leaders

advised on Australian Government funding including the Medical Research Future Fund and Cooperative Research Centre grants

invited Myeloid to join Austrade’s BIO23 delegation, where the company participated in panel discussions and attended Austrade’s investment roundtable.

Published: 3 September 2023

Singapore Success Story - Cerecin

Global pharmaceutical company Cerecin, which develops therapeutics for neurological disorders, is undertaking clinical trials and expanding its research capabilities in Melbourne, Australia. Charles Stacey, Cerecin’s President and CEO, explains why it has chosen Australia to expand its global footprint. Benefits include its diverse population mix, R&D incentives and human capital.

Contact an  Austrade Investment Specialist  in your region for more information about the pharmaceutical industry in Australia.

Published: 13 April 2023

Singapore Success Story - Homage

Singapore’s Homage is bringing its personalised aged care and support services platform to the Australian market. Homage co-founder and CEO Gillian Tee explains why Australia is a strategic location for growth.

Read more about Australia's growing aged care industry.

Contact an  Austrade Investment Specialist  in your region for more information about aged care in Australia.

Agility and innovation make Australia’s Linear a top clinical trials host

There was a time when Jayden Rogers had to explain to potential clients where Australia was and why they should conduct clinical trials here. Today, Australia is known as one of the best places in the world for clinical trials. This is in part due to the high-quality work undertaken by Rogers’ company, Linear Clinical Research.

Linear is an Australian not-for-profit organisation offering Phase I to Phase III clinical trials. To date, Linear has carried out over 420 studies in 20 therapeutic areas. It has worked with more than 300 sponsors from 18 countries. During the pandemic, the company saw record patient enrolments. It undertook over a dozen trials for COVID-19 therapeutics, two of which are now approved.

‘Australia has a well-deserved reputation as a world leader in clinical trials,’ says Rogers, Linear’s CEO. ‘We have a high-quality, advanced healthcare system, brilliant scientists and clinicians, and excellent R&D. Our streamlined regulatory approval process and generous research incentives also support international companies to conduct trials here.’

Tech innovation supports world-class trials

Founded in 2010, Linear has 2 state-of-the-art facilities in Western Australia. One of these is in the QEII Medical Centre, the largest medical precinct in the Southern Hemisphere.

Linear has a strong focus on Phase I healthy volunteer and Phase I cancer trials. The company has more than 100 early-phase cancer trials in its portfolio. It has one of the most active cancer trials team in the Asia-Pacific region.

Later in 2023, Linear will open a dedicated clinical trial private hospital for early-phase cancer trials. This will be the only one of its kind in Australia and it will triple Linear’s existing capacity.

Innovation has also played a part in Linear’s success. In 2017, the company was the first in Australia to install the eSource platform to capture data at the point of entry. It has also invested in telemetry and technology to monitor vital signs remotely. This investment in technology came to the fore during the pandemic.

‘Because we had electronic systems in place, we were able to switch to remote monitoring in just 7 days,’ says Rogers. ‘Our clinicians in Australia and clients in the US, Europe and China could view trial data in real time. It’s a collaborative way to run clinical trials.’

Clinical trials during COVID-19

Finding clinical trial participants during the pandemic was not an issue. In Western Australia, there is strong reach into many patient groups which are often consolidated into a small number of hospitals. This supports strong patient recruitment for clinical trials.

Linear also has over 40,000 healthy volunteer participants in its database. Australia’s multicultural population – 29% of citizens are born overseas – ensures a diverse patient cohort for clinical trials.

‘We delivered record enrolments for our cancer trials,’ says Rogers. ‘These patients would not have received treatment in other facilities. And we’re seeing amazing response rates. Up to 75% of patients observe some form of response with a small number experiencing complete responses (full remission) as a result of new therapeutics. It’s lifechanging.’

Linear also deployed its capabilities to support COVID-19 vaccine and therapeutic trials. The company worked with Chinese biotech Clover to undertake Phase I clinical trials for a vaccine candidate. It had the trial up and running in two weeks following ethics submission. The Phase I trial recruited 140 volunteers as a single site. This enabled a subsequent global Phase II/III trial that went on to demonstrate successful protection against COVID-19.

‘The Clover vaccine is now among the group of vaccines used in China,’ says Rogers. ‘It was thrilling to play a role in its development.’

Australia’s accelerated trial approval process

Linear undertook more than a dozen COVID-19 trials and prophylactic studies across a range of therapeutic modalities from 2020–2022. One of these was with Stanford University to trial an antibody to prevent COVID-19.

‘We worked around the clock with the Stanford researchers to help design the protocol,’ says Rogers. ‘Then we obtained ethics committee approval within 15 days, recruited patients and had the trial running within 20 days. It was the quickest clinical trial Linear has ever done. It is probably one of the quickest clinical trials in history, from the point of engagement to clinical execution and the delivery of data.’

Linear works with Bellberry, an organisation providing scientific and ethical review of human research projects. During the pandemic, Bellberry had an accelerated approval process for COVID-19 therapeutics and vaccines.

‘Australia’s pragmatic regulatory environment is one of our key strengths,’ says Rogers. ‘The Therapeutic Goods Administration delegates trial reviews to human-research ethics committees like Bellberry. This speeds approval times so clinical trials can be set up quickly but safely.’

Austrade paves entry into China

Almost all of Linear’s clients are international pharmaceutical or biotech firms. Most of them are from the US, followed by China and the EU. Rogers says Austrade was instrumental in helping Linear enter the Chinese market in 2017.

‘We’ve had tremendous support from Austrade over years,’ says Rogers. ‘The on-the-ground support in China was an important aspect of our growth in that market. Their staff went above and beyond. I would happily recommend Austrade to any business wanting to expand their overseas markets.’

Keeping innovation on the agenda

The past few years have seen major changes in therapeutics and approaches to clinical trials.

‘We’re seeing new molecules being tested, including bi-specific antibodies and drugs that target certain mutations based on genomics,’ say Rogers. ‘COVID-19 saw a shift to new treatments for infectious diseases and respiratory viruses. We’re seeing more targeted therapeutics, particularly mRNA therapeutics and cell therapies.

‘The world made a vaccine for COVID-19 in 12 months, thanks to research, industry and government working together,’ says Rogers. ‘At Linear, we want to keep pushing the innovation agenda. It’s the only way we can keep creating drugs that save lives.’

Contact an Austrade Investment Specialist in your region for more information about conducting clinical trials in Australia.

Published: 30 March 2023

You are using an outdated browser. Please upgrade your browser to improve your experience.

Browse Research Oceania Australia All Categories Life Sciences Healthcare Region: Australia Category : Healthcare

Australia Healthcare

Refine your search, australia industrial gases market, by product type (nitrogen, oxygen, carbon dioxide, hydrogen, ammonia, methane, propane, butane, others (nobel gases)); by mode of distribution (tonnage, packaged, bulk); by application (packaging, coolant, cutting & welding, laboratories, others (air separation, cryogenic)); by end user (electronics, food & beverages, oil & gas, medical & pharmaceutical, automotive & transportation, energy & power, others (chemical processing & refining, metal manufacturing & fabrication), trend analysis, competitive landscape & forecast, 2019–2030.

Mar 12, 2024  |  Published by: BlueWeave Consulting  |  USD 2,950

... Others (Air Separation, Cryogenic)); By End User (Electronics, Food & Beverages, Oil & Gas, Medical & Pharmaceutical, Automotive & Transportation, Energy & Power, Others (Chemical Processing & Refining, Metal Manufacturing & Fabrication), Trend Analysis, Competitive ... Read More

Asia Pacific Lancet and Pen Needles Market, By Length (4mm, 5mm, 6mm, 8mm, Others); By Gauge (17/18G, 21G, 23G, Others); By Application (Blood Glucose Monitoring, Insulin Delivery, Others); By Mode of Purchase (Retail, Non-retail); By End User (Clinics, Hospitals, Medical Institutions, Others); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030

Mar 01, 2024  |  Published by: BlueWeave Consulting  |  USD 3,599

... By End User (Clinics, Hospitals, Medical Institutions, Others); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 Asia Pacific ... Read More

Aged Care Residential Services in Australia - Industry Market Research Report

Feb 29, 2024  |  Published by: IBISWorld  |  USD 790

... range of age-related ailments and need more assistance with everyday activities and personal care. The Aged Care Residential Services industry is growing as aged care requirements are changing, and operators now offer different lifestyle accommodation ... Read More

Chiropractic and Osteopathic Services in Australia - Industry Market Research Report

Feb 22, 2024  |  Published by: IBISWorld  |  USD 790

... industry in recent years. For example, a rise in the number of individuals suffering from long-term health conditions, including diseases of the musculoskeletal system and connective tissues, has supported the need for chiropractic and osteopathic ... Read More

Psychiatric Hospitals in Australia - Industry Market Research Report

Feb 20, 2024  |  Published by: IBISWorld  |  USD 790

... which are favouring community-based psychiatric treatments. Community-based preventative treatments for outpatients have driven some demand away from the industry as the government has increasingly focused on preventing the need for more costly treatment in psychiatric ... Read More

Australia Pet Grooming Products Market Segmented By Animal (Dog, Cat, Horse, and Others (Birds, Reptiles, Small Mammals (Rat & Mice, Mouse, Rabbit, Guinea Pig, etc.)), By Product (Shampoo & Conditioners, Clippers & Scissors, Brushes & Combs, Blades, Dental Care Tools, and Others (Dryers, Fragrances, Wipes, etc.)), By Sales Channel (Supermarkets/Hypermarkets, Pet Specialty Stores, Online, and Others (Distributors/Dealers, Direct Sales, Veterinary Clinics, etc.)), By Region, Competition, Forecast and Opportunities, 2019-2029F

Feb 19, 2024  |  Published by: TechSci Research  |  USD 3,500

... & Combs, Blades, Dental Care Tools, and Others (Dryers, Fragrances, Wipes, etc.)), By Sales Channel (Supermarkets/Hypermarkets, Pet Specialty Stores, Online, and Others (Distributors/Dealers, Direct Sales, Veterinary Clinics, etc.)), By Region, Competition, Forecast and Opportunities, 2019-2029F ... Read More

Asia Pacific Cosmetic Surgery Market, By Procedure (Facial Procedures, Body Contouring Procedures, Breast Procedures, Genital Rejuvenation, Non-Surgical Procedures, Others); By Product Type (Implants, Injectables, Equipment, Surgical Sutures & Skin Staplers, Others); By End User (Ambulatory Surgical Units, Hospitals & Clinics, Cosmetic Surgical Centers, Others); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030

Feb 08, 2024  |  Published by: BlueWeave Consulting  |  USD 3,599

... (Ambulatory Surgical Units, Hospitals & Clinics, Cosmetic Surgical Centers, Others); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 ... Read More

Other Health Services in Australia - Industry Market Research Report

Jan 30, 2024  |  Published by: IBISWorld  |  USD 790

... to form individual industries. Relevant allied health services include audiology, dietetics, midwifery, nursing, occupational therapy, podiatry, psychology and speech therapy. Alternative health therapies include acupuncture and natural therapies. The industry also includes blood banks, and ... Read More

Dental Services in Australia - Industry Market Research Report

Jan 19, 2024  |  Published by: IBISWorld  |  USD 790

... the industry is predominantly privately funded. While most individuals pay for dental check-ups and procedures with their own income, some use private health insurance extras cover to subsidise the cost. Patients with private health coverage ... Read More

Community Services in Australia - Industry Market Research Report

... and counsel for individuals in need, including the economically disadvantaged and other vulnerable members of society like children and the elderly. Favourable demographic trends and ongoing government funding have supported the subdivision's performance in recent ... Read More

Australia and New Zealand Point-of-Care Diagnostic Ultrasound Market Size and Forecast (2020 - 2030), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (2D, 3D/4D, and Others), Portability (Trolley and Compact/Handheld), Application (General Imaging, Surgery, Cardiology, and Others), and End User (Emergency Department, Intensive Care Critical Care, Operating Theatre, IVF Clinics, Physiotherapy Centers, Sports Medicine, General Practitioner, Respiratory Center, Anesthesia, and General Wards)

Jan 18, 2024  |  Published by: The Insight Partners  |  USD 3,550

... (General Imaging, Surgery, Cardiology, and Others), and End User (Emergency Department, Intensive Care Critical Care, Operating Theatre, IVF Clinics, Physiotherapy Centers, Sports Medicine, General Practitioner, Respiratory Center, Anesthesia, and General Wards) The Australia and New ... Read More

Corporate Wellness Services in Australia - Industry Market Research Report

Jan 11, 2024  |  Published by: IBISWorld  |  USD 790

... and leading to more people working away from offices. Greater recognition of mental health issues and their effects in the workplace has buoyed industry growth. Employee burnout has also emerged as a growing concern, buttressing ... Read More

Cannabis in Australia

Jan 05, 2024  |  Published by: Euromonitor International  |  USD 1,675

... to and the safety of medical cannabis through legalisation, as opposed to outright bans on product usage. Growth in the category is, however, still limited by high costs, the reluctance of medical practitioners to prescribe ... Read More

General Practice Medical Services in Australia - Industry Market Research Report

Nov 29, 2023  |  Published by: IBISWorld  |  USD 790

... health problems and referring patients to specialists or general hospitals. The Australian population's age profile is a strong demand determinant for general practice medical services. Australia's population has been ageing rapidly, as more baby boomers ... Read More

Health Services in Australia - Industry Market Research Report

... for over half of Australia's health services revenue. General practitioners (GPs), clinical specialists and dentists also represent significant revenue streams for the subdivision. While Australia's growing and ageing population has bolstered demand for health services ... Read More

Specialist Medical Services in Australia - Industry Market Research Report

... Greater demand, along with moderate growth in fees, has boosted industry revenue growth over the past five years. The Federal Government supports qualified specialists through Medicare, which funds a schedule fee that covers part or ... Read More

Veterinary Services in Australia - Industry Market Research Report

... COVID-19 pandemic, higher pet insurance uptake, growing awareness of animal health, and the increasing availability of advanced surgical and diagnostic procedures for animals have benefited the veterinarians. Pet owners are becoming increasingly willing to spend ... Read More

National Disability Insurance Scheme Providers in Australia - Industry Market Research Report

... pumped more and more funding into the scheme. Disability service providers have benefited greatly from new funding arrangements, as market-based arrangements support many disabled individuals across Australia. Some individuals receive National Disability Insurance Scheme (NDIS) ... Read More

Private General Hospitals in Australia - Industry Market Research Report

... Approximately one-third of Australia's hospitals are operated by private for-profit operators, and not-for-profit religious and charitable institutions. Australia's ageing population and climbing rates of obesity and chronic disease have supported demand for private hospital services ... Read More

Asia Pacific Multiple Sclerosis Drugs Market, By Disease Type (Relapsing-Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS), Primary Progressive Multiple Sclerosis (PPMS), Severe Relapsing-Remitting Multiple Sclerosis (RES)); By Treatment (Preventive Therapies, Abortive Therapies/Treatment of Acute Exacerbations, Symptomatic Therapies); By Drug Type (Branded, Generic); By End User (Hospital & Clinics, Diagnostic Laboratories); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Competitive Landscape & Forecast, 2019–2029

Nov 10, 2023  |  Published by: BlueWeave Consulting  |  USD 3,599

... By End User (Pharmaceutical & Biopharmaceutical Companies, Labs & Research Institutes, Healthcare Providers, Healthcare Payers); By Application (Drug Discovery & Development, Medical Diagnostics, Genomics & Precision Medicine, Radiotherapy, Risk Analysis); By Region (North America, Europe, ... Read More

Australia & New Zealand Cannabis Extraction & Analytical Testing Market Forecast 2023-2030

Nov 04, 2023  |  Published by: Inkwood Research  |  USD 1,100

... during the forecast years, 2023 to 2030. Australia is one of the largest importers of unapproved medical cannabis products, as well as cannabis for scientific purposes worldwide, along with Israel and Germany. MARKET INSIGHTS In ... Read More

Telehealth in Australia - Industry Market Research Report

Oct 25, 2023  |  Published by: IBISWorld  |  USD 785

... height of the pandemic. This growth has largely been due to an expansion of the Medicare Benefits Schedule (MBS) to support telehealth services during the pandemic. In addition, patients have been more likely to use ... Read More

Asia-Pacific Group Health Insurance Market, By Plan Type (Mixed-insured Plan, Self-Insured Plan, Fully Insured Plan); By Enterprise Size (Large Enterprises, Micro, Small, and Medium-sized Enterprises (MSMEs)); By Distribution Channel (Agents, Direct Sale, Banks); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Competitive Landscape & Forecast, 2019–2029

Oct 25, 2023  |  Published by: BlueWeave Consulting  |  USD 3,599

... Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Competitive Landscape & Forecast, 2019–2029 Asia-Pacific Group Health Insurance Market Size Set to Grow at Significant CAGR of ... Read More

Veterinary Laboratory Testing Services in Australia - Industry Market Research Report

Oct 20, 2023  |  Published by: IBISWorld  |  USD 785

... testing services involve testing and diagnosing animal-related diseases in laboratories. These services include blood and serum analysis, toxicology, parasite test services, virology, bacteriology and mycology. These services are essential in Australia, given the economic importance ... Read More

Plastic Surgeons in Australia - Industry Market Research Report

Oct 13, 2023  |  Published by: IBISWorld  |  USD 770

... overweight and obese individuals in Australia, and population growth in target demographics, including middle-aged and older females, have been the key drivers for the industry. Increasing social acceptance of plastic surgery has made potential customers ... Read More

< prev 1 2 3 4 next >

Matching Categories

• Alternative & Complementary Medicine (7)
• Ambulance (2)
• Blood Supply, Tissue Banking, Transplantation (1)
• Country Overviews (2)
• Facilities (58)
• Information Technology (4)
• Insurance & Managed Care (2)
• Nursing (1)
• Services (19)
• Sports Medicine (1)
• Veterinary Health (13)
• Wellness/Prevention Programs (3)

Research Assistance

Join Alert Me Now!

• [email protected]

• B2B Market Research
• Brand Market Research
• Concept & Product testing
• Consumer Market Research
• Consumer Online Panel
• Global Physicians Panel
• Healthcare Market Research
• Omnibus Research
• Online Market Research
• Tracking Research
• Focus Groups / Online Focus Groups
• Ethnographic Market Research
• In-Depth Interviews
• Online bulletin boards
• Usability and Testing Research
• Face to Face Interviews
• Online Surveys
• Computer Aided Telephonic Interviews (CATI)
• Computer Assisted Personal Interviews (CAPI)
• Central Location Test
• Animal Health
• Automotive Industry
• Banking and Financial Services
• Chemical Industry
• Consumer Health
• Consumer Packaged Goods
• Energy and Utilities
• Food and Drinks
• Government and Public Sector
• IT and Telecommunication
• Medical Devices and Diagnostics
• Pharmaceuticals
• Retail Industry
• Travel & Tourism
• Esomar 28 Questions
• Market Research Associations
• Research Methods
• Terms of Business
• Privacy Policy
• Animal Health Market Research
• Automotive Market Research
• Banking and Financial Services Market Research
• Chemical Market Research
• Consumer Health Market Research
• Consumer Packaged Goods Market Research
• Energy and Utilities Market Research
• Food and Drink Market Research
• Government and Public Sector Market Research
• IT and Telecommunication Market Research
• Research Services

Healthcare Market Research in Australia

Australia officially the Commonwealth of Australia is a sovereign country comprising the mainland of the Australian continent, the island of Tasmania and numerous smaller islands. It is the largest country in Oceania and the world’s sixth-largest country by total area.

Australia is a wealthy country; it generates its income from various sources including mining-related exports, telecommunications, banking, and manufacturing. It has a market economy, a relatively high GDP per capita, and a relatively low rate of poverty.

InVeritas Research is one of the top providers of  pharmaceuticals and healthcare market research in Australia . We are a full service quantitative and qualitative market research Fieldwork Company committed to providing high-quality data collection and market research services.

We are among the best company for pharmaceuticals and healthcare market research in Australia for recruiting difficult to reach audiences and quality data collection and have in-depth experience of applying suitable methodologies across a wide range of different industries, geographies, and cultures. We are consistently making an impact on the growth of our clients’ businesses.

Types of different market research and data collection we do:

Face to Face Market Research in Australia InVeritas Research with its team of highly trained and experienced professionals has successfully conducted many F2F with consumers, decision makers and healthcare professionals in Asia, Europe, Africa and North and South American regions either directly or with the help of trusted partners.

We help our client to identify the target audience and understand perspectives and experiences of a particular industry or community and further help them to gain insight and strategize their approach.

Central Location Tests in Australia

Central location test is the practical way of implementing the survey which ensures high-quality results and offers key advantage of Face to Face interview which is the ideal for conducting many tests like the introduction of the new or modified product.

InVeritas Research with its team of highly trained and experienced professionals has successfully conducted Central location testing in Asia, Europe, Africa and North and South American regions.

Computer Aided Telephonic Interviews in Australia (CATI)

  Our CATI team works closely with clients to understand the needs and accordingly the project is designed and executed. We have 20 professionally trained and experienced CATI interviewers with a multilingual capability and our strong quality control team which analyses every interview so that the client gets the highest quality deliverables.

Computer Assisted Personal Interview in Australia (CAPI)

CAPI researchers help to control the interview processes as the interviewer is present with the respondents at the time of interview and after the interview, the data collected is sent to the central computer through a secured connection.

We had have successfully conducted many CAPI researches in Asian and the Middle East countries using our proprietary panel as well as through our trusted partners for B2B, B2C, Physicians Specialist, Allied Healthcare Professionals, KOL’s and C-level Executives.

Online Surveys in Australia

InVeritas research is one of the Global leading providers of Consumers, B2B and Healthcare Online Market Research in the industry.

With over  4 million Consumer and B2B panelists across 25+countries  and more than  400,000+ Physicians of 70+ specialties  across the globe makes us stand out among all.

In-Depth Interviews in Australia

In-Depth Interviews are qualitative data collection method which helps to analyze, explore, study perception, attitude and respondent behavior to a particular idea or concept. The questions are open-ended, less structured, flexible and continuous.

We at InVeritas Research have conducted many IDI’s in different geography in persona and over the phone with difficult to reach respondents who are identified as potential source of information and allows the researcher and respondent latitude to explore an issue within the framework of the guided conversation

Focus Groups / Online Focus Groups in Australia

InVeritas Research market research services use Focus group discussions for consumers or businesses to collect data and insights which are most of the time less known to the provider.

Focus group discussions are more effectively utilized when the objective of the investigators is to understand consumers or professional’s views and gain in-depth insights which can be used to provide the client with data and greater clarification to determine their strategy.

Ethnography Studies in Australia

Ethnography is a kind of research conducted within the context of consumer experience, social interaction, behaviors and perceptions in the real world within teams, groups, organizations, and communities. It helps to understand the consumer’s environment through direct observation and exploration of their social, economic and cultural aspects which affects and influences their product selection and uses traditionally in consultation with an Anthropologist.

Online Bulletin Boards in Australia

InVeritas Research uses Online Bulletin board for researches involving long-term discussions which allows the respondents to share their opinion and thoughts more clearly, additionally, participants can log in at their convenience which allows more time to express their thoughts and provide richer insights.

Usability Testing in Australia

InVeritas Research focuses on to get a high-value aspect of the user experience which affects user satisfaction by determining their perception, needs, and anticipated cost and in turn profitability.

Pharmaceuticals Market Research in Australia:

InVeritas Research with its team of highly experienced leaders and directors who have spent almost 15-25 years in the pharmaceutical industry, working across different geography and different level has made conducting research processes and understanding unmatched deep insights easy for clients.

Medical Devices Market Research in Australia:

InVeritas Research has successfully completed and delivered over 150 projects on Medical devices of different specialties in European, Middle-East, Asia and North and South American Market.

Our team of highly experienced Project Manager, Consultants, and directors who have spent almost 10-20 years in the Medical devices industry, working across different geography and different level has made conducting research processes and understanding unmatched deep insights easy for clients.

Industries We Serve

• Food and Drink
• Medical Devices and Diagnostic

Your Name (required)

Your Email (required)

Your Message

discover tomorrow today

Our promise, too often, we see businesses confusing data with insights, but data alone is not enough.

We are an independent Australian market research company that provides organisations with insights about their markets and customers by layering context and expertise on top of data.

This allows our clients to make better decisions and unlock tomorrow’s opportunities today.

This is fifth quadrant.

We believe in doing the right thing, even when it’s not easy. We are honest and transparent in our work, ensuring the accuracy and integrity of research data, and always striving to uphold the highest ethical standards.

Improvement

We believe that continuous learning is essential for success. We encourage our employees to take on new challenges and to grow their skills and knowledge. We provide opportunities for professional development and growth, and we support our employees in reaching their full potential.

Inclusiveness

We believe that diversity of thought makes us stronger. We value the contributions of all of our employees, we celebrate their backgrounds and experience. We create a safe and supportive work environment where everyone feels welcomed and respected.

We are always looking for new ways to improve our work, staying at the forefront of research methodologies, technologies and industry trends so we can provide our clients with the best possible solutions. We are constantly learning and adapting and are always open to new ideas.

Involvement

We believe that it is our responsibility to give back to the community. We are actively involved in supporting local organisations and initiatives. We believe that by working together, we can make a positive impact on the world.

Case Studies

crafting a winning discount program

brand strategy for lenscare solutions

supporting a new product launch

multinational study into eCommerce & payment trends

Building a customer-centric culture at a local council

social enterprise thought leadership

designing responsible AI systems

brand health in the road freight transport sector

brand strategy for companion animal anesthesia

designing better private health insurance

brand tracking in consumer healthcare

brand tracking in the skincare market

supporting GP’s delivery of youth sexual healthcare

construction industry thought leadership

customer experience tracking for state government

delivering a seamless home building experience

demand for net zero homes in the US

improving patient outcomes for STI and HIV care

local council customer-centricity

making a brand recommendation claim for pet calming supplements

meeting home loan customer needs and expectations

optimising operational efficiency in the mining sector

retaining automotive servicing customers

service station customer value proposition development

SME segmentation model for the telecommunications industry

tracking the business finance landscape & opportunity

uncovering insights in the australian automotive industry

ACA Research is now Fifth Quadrant

We are thrilled to unveil our fresh brand identity as fifth quadrant.

While our name has changed, our values have not. Our aim is to be more than just a research partner. We want to be a catalyst for change, a strategic advisor, and a trusted ally for our clients as they navigate a rapidly evolving business environment.

The new fifth quadrant brand aligns with our mission to deliver real insights that shape the future of your business, and empower you to discover tomorrow, today.

Reach out if you’d like to find out more.

Australia Health and Wellness Market

Australia health and wellness market report by product type (functional foods and beverages, beauty and personal care products, preventive and personalized medicinal products, and others), functionality (nutrition and weight management, heart and gut health, immunity, bone health, skin health, and others), and region 2024-2032.

• Report Description
• Table of Contents
• Methodology
• Request Sample

Market Overview:

Australia health and wellness market size is projected to exhibit a growth rate (CAGR) of XX% during  2024-2032 . The integration of technology in health and wellness solutions, such as wearables, mobile apps, telemedicine, and health tracking devices, which make it easier for individuals to monitor and manage their health, is primarily driving the regional market.

Health and wellness encompass a holistic approach to maintaining and improving one's overall well-being. It goes beyond the absence of illness and emphasizes the integration of physical, mental, and social aspects of life. Achieving health involves adopting positive lifestyle choices, such as regular exercise, balanced nutrition, and sufficient sleep. Mental and emotional well-being are equally vital, encompassing stress management, mindfulness, and emotional resilience. Additionally, fostering strong social connections and a supportive community contributes significantly to overall wellness. Striving for a harmonious balance in these various dimensions leads to a more fulfilling and healthier life. Regular health check-ups and preventive measures also play a crucial role in maintaining optimal physical health. Ultimately, health and wellness empower individuals to lead active, meaningful lives and prevent the onset of diseases, promoting longevity and a higher quality of life.

Australia Health and Wellness Market Trends:

The health and wellness market in Australia is experiencing robust growth, driven by several interconnected factors. Firstly, the increasing awareness of the importance of a healthy lifestyle has spurred a rising demand for wellness products and services. Consumers are becoming more conscious of their well-being, leading to a surge in the adoption of fitness programs, nutritional supplements, and preventive healthcare measures. Moreover, advancements in technology play a pivotal role in shaping the health and wellness landscape. The integration of wearable devices, mobile health apps, and telehealth services has empowered individuals to monitor and manage their health proactively. This tech-driven approach not only enhances accessibility to healthcare but also fosters a culture of self-care. Additionally, shifting demographics, with an aging population and a growing middle class in Australia, contribute significantly to the expansion of the health and wellness sector. This demographic shift is accompanied by an increased willingness to spend on health-related products and services, driving market growth. In essence, the dynamic interplay of awareness, technology, pandemic-driven priorities, and demographic trends collectively propels the regional health and wellness market forward.

Australia Health and Wellness Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product type and functionality.

Product Type Insights:

• Functional Foods and Beverages
• Beauty and Personal Care Products
• Preventive and Personalized Medicinal Products
• Others  

The report has provided a detailed breakup and analysis of the market based on the product type. This includes functional foods and beverages, beauty and personal care products, preventive and personalized medicinal products, and others.

Functionality Insights:

• Nutrition and Weight Management
• Heart and Gut Health
• Bone Health
• Skin Health

A detailed breakup and analysis of the market based on the functionality have also been provided in the report. This includes nutrition and weight management, heart and gut health, immunity, bone health, skin health, and others.

Regional Insights:

• Australia Capital Territory & New South Wales
• Victoria & Tasmania
• Northern Territory & Southern Australia
• Western Australia  

The report has also provided a comprehensive analysis of all the major regional markets, which include Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, and Western Australia.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Australia Health and Wellness Market Report Coverage:

Key questions answered in this report:.

• How has the Australia health and wellness market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Australia health and wellness market?
• What is the breakup of the Australia health and wellness market on the basis of product type?
• What is the breakup of the Australia health and wellness market on the basis of functionality?
• What are the various stages in the value chain of the Australia health and wellness market? 
• What are the key driving factors and challenges in the Australia health and wellness?
• What is the structure of the Australia health and wellness market and who are the key players?
• What is the degree of competition in the Australia health and wellness market?

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Australia health and wellness market from 2018-2032.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Australia health and wellness market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Australia health and wellness industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

India Dairy Market Report Snapshots Source:

Statistics for the 2022 India Dairy market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. 

• India Dairy Market Size Source
• --> India Dairy Market Share Source
• India Dairy Market Trends Source
• India Dairy Companies Source

Need more help?

• Speak to our experienced analysts for insights on the current market scenarios.
• Include additional segments and countries to customize the report as per your requirement.
• Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
• For further assistance, please connect with our analysts.

Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: [email protected]

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

• Competitive Intelligence and Benchmarking
• Consumer Surveys and Feedback Reports
• Market Entry and Opportunity Assessment
• Pricing and Cost Research
• Procurement Research
• Report Store
• Aerospace and Defense
• Agriculture
• Chemicals and Materials
• Construction and Manufacturing
• Electronics and Semiconductors
• Energy and Mining
• Food and Beverages
• Technology and Media
• Transportation and Logistics

Quick Links

• Press Releases
• Case Studies
• Our Customers
• Become a Publisher

United States

134 N 4th St. Brooklyn, NY 11249, USA

+1-631-791-1145

Level II & III, B-70, Sector 2, Noida, Uttar Pradesh 201301, India

+91-120-433-0800

United Kingdom

30 Churchill Place London E14 5EU, UK

+44-753-713-2163

Level II & III, B-70 , Sector 2, Noida, Uttar Pradesh 201301, India

We use cookies, including third-party, for better services. See our   Privacy Policy   for more. I ACCEPT X

Reset password

Reset Password

Market sectors

Research solutions, research services, north america, asia pacific, south america, middle east, enterprise partners.

View country informations

• United Kingdom (GB) (77)
• Germany (76)
• France (48)
• Greece (22)
• Netherlands (21)
• Sweden (20)
• Turkey (19)
• Switzerland (14)
• Russian Federation (13)
• Belgium (13)
• Denmark (9)
• Albania (1)
• Austria (12)
• Bosnia-Herzegovina (1)
• Bulgaria (11)
• Croatia (5)
• Czech Republic (5)
• Estonia (2)
• Finland (6)
• Hungary (2)
• Ireland (6)
• Lithuania (3)
• Macedonia (4)
• Montenegro (1)
• Poland (19)
• Portugal (10)
• Romania (12)
• Slovakia (1)
• Slovenia (4)
• Ukraine (2)
• Canada (23)
• United States (USA) (113)
• Australia (13)
• Azerbaijan (1)
• Bangladesh (3)
• Fiji Islands (1)
• Georgia (3)
• Hong Kong (4)
• Indonesia (11)
• Kazakhstan (5)
• Korea, Republic of (16)
• Kyrgyzstan (1)
• Malaysia (6)
• Mongolia (2)
• Myanmar (1)
• New Caledonia (1)
• New Zealand (4)
• Pakistan (7)
• Papua New Guinea (1)
• Philippines (6)
• Singapore (21)
• Sri Lanka (1)
• Thailand (11)
• Uzbekistan (2)
• Vietnam (4)
• Argentina (4)
• Bolivia (1)
• Brazil (15)
• Colombia (5)
• Costa Rica (3)
• Dominican Republic (1)
• El Salvador (1)
• Guatemala (1)
• Honduras (2)
• Mexico (15)
• Nicaragua (1)
• Iran, Islamic Republic of (4)
• Lebanon (4)
• Saudi Arabia (18)
• United Arab Emirates (27)
• Algeria (2)
• Cameroon (1)
• Congo, Democratic People's Republic (3)
• Côte d'Ivoire (3)
• Ethiopia (2)
• Madagascar (2)
• Mauritius (1)
• Morocco (7)
• Nigeria (8)
• Senegal (2)
• South Africa (9)
• Tunisia (1)
• Acorn Marketing & Research Consultants
• B2B International
• Euromonitor International
• GIM Gesellschaft für Innovative Marktforschung
• ARTIS Network
• WIN (Worldwide Independent Network of Market Research and Opinion Poll)
• Advertising / Public Relations (290)
• Agriculture (75)
• Airlines (23)
• Apparel / Clothing (32)
• Association Membership (6)
• Automotive (392)
• Beverages (346)
• Casinos/Gambling (6)
• Catering / Hospitality (25)
• Charity / Non-profit (37)
• Chemicals (24)
• Confectionery (71)
• Consultancy (218)
• Consumer Services (230)
• Cosmetics / Hygiene (256)
• Demographics
• Affluent (35)
• Children (28)
• College / University Students (24)
• Ethnic - General / Multi-cultural (30)
• Mature / Seniors (18)
• Mothers (34)
• Parents (32)
• Teenagers / Youth (40)
• Detergents (62)
• Direct Marketing (7)
• Durables / Electrical Goods (146)
• Education (51)
• Electronics (61)
• Energy / Utilities (84)
• Entertainment
• Entertainment Industry (56)
• Movie / Film / TV Previews (7)
• Music Tests (4)
• Theater Counts & Research (2)
• Environment & Ecology (40)
• Exercise & Fitness (8)
• Fashion Industry (20)
• Financial Services (439)
• Foods / Nutrition (476)
• Fragrance Industry (55)
• Gay & Lesbian Market (8)
• Healthcare / Pharmaceutical (527)
• IT / Software / Hardware (235)
• Legal / Lawyers (10)
• Logistic / Mail / Transportation (35)
• Cable / Satellite TV (12)
• Internet / Online (46)
• Print Publications (6)
• Television (22)
• New Products (155)
• Non-Profit / Fund Raising (13)
• Pet Owners / Foods / Supplies (20)
• Petrol / Oil / Gas (59)
• Political Polling / Planning (59)
• Public Sector / Government (219)
• Publishing (4)
• Real Estate (10)
• Retail / Wholesale
• Drug Stores / Pharmacies (25)
• Fast Food Industry (21)
• Mass Merchandisers (17)
• Restaurants / Food Service (23)
• Supermarkets (52)
• Service Industries (46)
• Social Development Organisations (33)
• Technology (152)
• Telecommunications (387)
• Textile / Fashion / Clothing (41)
• Tobacco / Cigarettes (119)
• Toys / Games (27)
• Travel / Tourism / Sport / Leisure (210)
• Advertising Research - General (214)
• Advertising Tracking (50)
• Copy Testing (41)
• Media attribution & modelling (4)
• Brand Research (460)
• Business Intelligence services & solutions (30)
• Business-to-business (421)
• Children / Youth's Research (68)
• Concept / Positioning Development (88)
• Concept Testing (242)
• Consumer Research (742)
• Corporate Image Research (37)
• Customer Satisfaction Studies (353)
• Demographic Research (45)
• Employee Research (77)
• Ethnographic Research (154)
• Focus Groups Facilities (82)
• Image Studies (76)
• International Studies (319)
• Knowledge Management (9)
• Lifestyle & Value Trends (33)
• Media Research - General (88)
• Audience Research (70)
• Internet / Online/Mobile (47)
• Media Attribution / ROI (4)
• Outdoor Media Research (1)
• Print Publications (4)
• Television (13)
• Modeling & Predictive Research (10)
• New Product Research - General (226)
• Car Clinics (63)
• Home Use Tests (iHUT) (60)
• New Product Development (90)
• Packaging / Design (108)
• Product / Sensory Testing (206)
• Product Lifecycle Management (2)
• Online/Mobile Panel (216)
• Pricing Studies (113)
• Projective Techniques (59)
• Psychographic Research (15)
• Psychological / Motivational Research (35)
• Opinion Polling (148)
• Political Polling (27)
• Public Opinion Research (116)
• Reputation Research (22)
• Controlled Store Tests (10)
• Exit Interviews (57)
• Mystery Shopping (171)
• Price & Promotion (3)
• Sales Tracking (8)
• Shopper Insights (74)
• Store Audits (57)
• Scenario Planning (12)
• Segmentation Research (162)
• Semiotic and Cultural Analysis (41)
• Senior Citizen / Mid-life (20)
• Social Research (82)
• Syndicated Research (50)
• Tracking Studies (262)
• Usage & Attitude Studies (343)
• Validation Services (10)
• Website Usability (34)
• Big Data (31)
• Data Audit & Exploration (incl enrichment & integration) (2)
• Data Driven Consultancy (15)
• Data Mining and Analysis (94)
• Data Science Services (14)
• Modeling and Forecasting Analysis (10)
• Segmentation Analysis (51)
• Statistical Analysis (184)
• Eye Tracking (32)
• Facial Scanning (9)
• Neuroscience / Neuromarketing / Neuromonitoring (18)
• Advertising / Communication (41)
• Audience / Media Measurement (12)
• Behavioural Economics (9)
• Business-to-Business Research (81)
• Consumer Research (86)
• Crowdsourcing (5)
• International Research (104)
• Marketing Research (100)
• New Product Research (65)
• Political / Opinion Research (19)
• Social / Cultural Research (28)
• Data Collection Management (102)
• Desk Research (230)
• Field Audits (23)
• Field Department - Independent (27)
• Gamification (7)
• Omnibus Surveys (85)
• Pre-Recruiting (25)
• Questionnaires (52)
• Sampling (47)
• Mobile Ethnography (31)
• Mobile Panels (24)
• Mobile Phone Surveys (33)
• Mobile Qualitative (29)
• Mobile Quantitative (13)
• Panels - General (157)
• Mobile Passive / Behavioural (1)
• Online Passive / Behavioural (3)
• Communities (16)
• Online (48)
• Telephone (26)
• Creativity / Ideation Workshops (36)
• Focus groups (441)
• In-depth interviews (361)
• Online Focus Groups / Bulletin Boards (173)
• Recruiting (243)
• Semiotics Research and Analysis (21)
• Sensory Research (34)
• Mystery shoppers (223)
• Online (337)
• Research Software - General (28)
• Coding and Analysis (1)
• Communities (10)
• Ethnography (19)
• Focus groups and chats (25)
• Coding and Text Analysis (6)
• Panel Management (11)
• Reporting, Presentation, Data Visualisation (22)
• Statistical Analysis (10)
• Survey (questionnaire, sampling) (24)
• Business Insights (19)
• Monitoring and Analysis (25)
• Qualitative (38)
• Sample & Recruiting (25)
• Automation (2)
• Business Intelligence Tools (5)
• Database Development (14)
• Incentives management (2)
• NLP Systems (1)
• Platform and Cloud (incl SaaS) (4)
• Platform Maintenance (1)
• Scanning Services (4)
• Text Analysis (4)
• Translation (2)
• Visualisation & Infographics (1)
• Mobile Data Provider (2)

Market research conducted in Australia

List of data, research and insights companies and services c onducting research in Australia. Click to view detailed company profiles, get contact information and more. To view the result based on company location and/or specialization, please use the filters below.

Tip! Try looking at only companies that are located in Australia , instead of all those conducting their services there. Yes, show me!

Add filters:

Full list of specializations

Sponsored results

Ipsos Australia

2060 Sydney, Australia

Ipsos is one of the largest market research and polling companies globally, operating in 90 markets and employing over 18,000 people. Ipsos provides True Understanding of Society, Markets and People.

SIS International Research

200021 Shanghai, China

SIS International Research is a full-service global market research firm offering qualitative fieldwork, quantitative data collection, strategic research, desk research and market intelligence solutions.

i-Link Research Solutions

2000 Sydney, Australia

Founded in 2001, i-Link is an independent research bureau providing a full suite of field, recruitment, analysis and DP services. Our proprietary applications and research tools include an advanced…

1 + 1 Research Group

400101 Mumbai, India

1 + 1 Research is a global full-service Qualitative and Quantitative research company providing primary data collection services. The company's global footprint extends to Asia, Europe, and Latin America and our client list includes some of the world's most reputed and successful organisations.

2 insights Research Ltd

HX1 2EU Halifax, United Kingdom (GB)

2insights Research is a leading market research company in the UK. We are a Full-Service Market research company and provides Qualitative and Quantitative Research. Our team is an expert in Recruitments, Focus Group, IDI, Data Collection using CAPI, CAWI, CATI and Market Research Surveys

HP22 5EJ Aylesbury, United Kingdom (GB)

2Europe are an award-winning, full-service market research agency which specialises in B2B and Consumer market research. We provide domestic and international quantitative and qualitative research services, as well as secondary/desk research services. All our projects are tailored to client needs.

1495-061 Algés, Portugal

We act dedicated to the Healthcare sector, having different expertise areas and being a strategic advisor to many of the leading companies in the market. We combine our research capabilities with deep scientific and market knowledges. Come to know us!

3Gem Media Group

ME1 1DA London, United Kingdom (GB)

3Gem global market research helps you to understand your audience, get a measure of your market, gather feedback on new concepts and drive PR and marketing campaigns. We deliver accurate research data and actionable insights so you can make informed decisions about your business.

A Keynote Research Group Company

421301 Mumbai, India

Keynote Research Private Limited - founded with an objective of providing cutting edge research advisory and consultancy services along with the fieldwork services across Asia, Middle East, Europe, North Africa and Americas.

Acacia Avenue

EC1V 1LR London, United Kingdom (GB)

We are a strategic research consultancy offering both qualitative and quantitative research. We help our clients make better business decisions than they would make without us.

Ace Fieldwork China (SHBJGZ)

510180 Guangzhou, China

Ace Fieldwork is a full-range company based in Shanghai, China with branch offices in Beijing and Guangzhou, China.

Acorn Marketing & Research Consultants Japan Co. Ltd

101-0024 Tokyo, Japan

ACORN is one of the largest independent Asian research groups providing strong local insights across Asia. We specialize in problem solving research and modeling including: ethnographic exploration,…

Acorn Marketing & Research Consultants Pte Ltd

238961 Singapore, Singapore

ACORN is one of the largest independent Asian research networks providing strong local insights across Asia. We specialize in problem solving research and modeling including: brand & product…

Acorn Organization Limited

Hong Kong, China

Acorn is one of the largest independent research network in Asia, managing research in more than 30 countries around the world. As pioneers in the industry, we are at the cutting edge of research, providing actionable insights grounded on over 30 years of experience.

Acuity Knowledge Partners

10016 New York, United States (USA)

Acuity Knowledge Partners is a global research & analytics firm. Market Research unit offers full service MR services incl. B2B & B2C Online Surveys, Survey Programming, Data Processing, Dashboards, Charting, Coding, Email Campaign, Survey Hosting & Panel Management, Report writing & Data Analytics

AD HOC RESEARCH

69006 Lyon, France

AD'HOC research is a full service company working with clients across all consumer, trade, financial, industrial, services and public sector markets. AD'HOC has two offices in France and works at…

11222 Brooklyn, United States (USA)

We’re Adience. We’re a B2B market research consultancy that gives you answers you can trust, from a team you actually like working with.

ADK Insights

2132 JC Hoofddorp, Netherlands

ADK Insights champion the consumers' voice and inspire brands to shape ideas, products and communications in ways that connect with today and anticipate tomorrow. We analyze and navigate all the many opportunities that could be, and help clients become fully future literate.

Advent Insight Solutions

19958 Lewes, United States (USA)

Advent Insight Solutions is a stage to serve all business requests. We have an exceptionally clear thought regarding the objectives and destinations of the business examine. We do Online Studies, Consumer Surveys, B2B Surveys, Customer/Employee Satisfaction Surveys, Brand Image and Awareness Studies

Agape International Market Research, S.A. de C.V.

54730 Cuautitlán Izcalli, Mexico

AGAPE Market Research is Global Field Work and Market Research Partner with unique service portfolio based on Five Principals: Accuracy, On-Time Delivery, Quick and 24x7 Support, Cost effectiveness, Quality Control. We support our clients in 72 countries across 14 Industries! .

S-114 31 Gustavsberg, Sweden

Altiant (formerly RCR) is a fieldwork company solely focused on delivering world class, affluent survey respondents to assist with luxury and wealth management research projects.

APLUSA Healthcare Marketing Research

69003 Lyon, France

APLUSA is one of the world’s leading independent market research companies dedicated to healthcare. We are now, globally, among the Top 5 Global Healthcare Market Research Companies, and the Top 3 Independent Players.

• Our Solution
• Food & Beverage
• Chemical & Materials
• Semiconductors and Electronics
• Materials & packaging
• Agriculture & Animal Feed
• Industrial Automation
• OIL, GAS & ENERGY
• Cloud Solutions
• Procurement Consulting
• Company Profile Analysis
• Primary Research
• DBMR Market Position Grid
• Bulk Report
• Industry Subscription
• Annual Update
• Quarterly Update
• Pharma Insights
• Market Insights
• Press Release
• Infographics
• White Paper
• Case Studies
• Business Case Studies
• COVID-19 Resources
• Our Company
• Company News Room
• Investor Relations

• US: +1 614 591 3140 UK: +44 845 154 9652 APAC : +653 1251 975
• Database Cloud Login
• Healthcare IT

Australia Private Health Insurance Market - Industry Trends and Forecast to 2029

• Published Report
• Country Level
• No of Tables: 35
• No of Figures: 29
• Report Description
• Table of Content
• List of Table
• List of Figure
• Request for TOC
• Speak to Analyst
• Inquire Before Buying
• Free Sample Report

Australia Private Health Insurance Market, By Type (Critical Illness Insurance, Individual Health Insurance, Family Health Insurance, Disease-Specific Insurance and Others), Health Plan Category/Metal Levels (Bronze, Silver, Gold Platinum and Others), Provider Type (Health Maintenance Organizations (HMOS), Preferred Provider Organizations (PPOS), Exclusive Provider Organizations (EPOS), Point-Of-Service (POS) Plans, High-Deductible Health Plans (HDHPS) and Others), Age Group (Young Adulthood (19-44 Years), Middle Adulthood (45-64 Years) and Older Adulthood (65 Years And Above)), Distribution Channel (Direct Insurance Companies, Insurance Aggregators and Others) Industry Trends and Forecast to 2029.

Market Analysis and Size

A health insurance policy consists of several types of features and benefits. It provides financial coverage to policyholders against certain treatments, health insurance policy offering advantages including cashless hospitalization, pre and posts hospitalization coverage, reimbursement, and various add-ons.

In the health insurance plan, several types of coverage are available: cashless or reimbursement claim. The cashless benefit is available when the policyholder takes treatment from the network hospitals of the insurance company. If the policyholder takes treatment from the hospitals that are not in the list network, in that case, the policyholder meets all the medical expenses and then claims for reimbursement in the insurance company by submitting all the medical bills.

These private health insurance provides financial support to the policy holder as it covers all the medical expenses when the policyholder is hospitalized for the treatment. Data Bridge Market Research analyses that the private health insurance market is expected to reach the value of USD 30,715.92 million by the year 2029, at a CAGR of 2.5% during the forecast period. " Individual Health Insurance” accounts for the most prominent type segment in the respective market owing to rise in private health insurance. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, and climate chain scenario.

Market Definition

Health insurance is a type of insurance that provides coverage for all kinds of surgical expenses and medical treatment incurred from the illness or injury. Health insurance applies to a comprehensive or limited range of medical services that cover the full or partial costs of specific services. Health insurance provides financial support to the policyholder as it covers all the medical expenses when the policyholder is hospitalized for the treatment. Health insurance also covers pre as well as post-hospitalization expenses.

Regulatory Framework

According to Private Health Insurance (Prudential Supervision) Act 2015

A private health insurer must have at least one health benefits fund. There are regimes governing:

How health benefits funds are operated; and

Changing the health benefits fund to which a policy of insurance is referable; and

Terminating health benefits funds; and

External management of health benefits funds.

COVID-19 had a Minimal Impact on Private Health Insurance Market

COVID-19 impacted various manufacturing and service providing industries in the year 2020-2021 as it led to the closure of workplaces, disruption of supply chains, and restrictions on transportation. Though, the imbalance between demand and supply and its impact on pricing is considered short-term and is expected to recover as this pandemic comes to an end. Due to outbreak of covid19 throughout the globe, the demand for private health insurance has increased tremendously. Also, the fear of pandemic and the increased cost for medical services helped the health insurance market grow during pandemic. In addition, health insurance companies introduced packages and solutions for covering the medical costs for treating covid19 infected insurers. Thus, even though the other industries suffered a lot during covid19 outbreak, the private health insurance industry was growing significantly.

The Market Dynamics of the Private Health Insurance Market Include:

Drivers/Opportunities

• Increasing cost of medical services

Health insurance provides financial support in cases of serious sickness or accident. Increasing medical services’ costs for surgeries and hospital stays has created a new financial epidemic worldwide. The cost of medical services is comprised of the cost of surgery, doctor fee, hospital stay cost, cost of the emergency room, and diagnostic testing cost, among others. Therefore, this increase in the cost of medical services propels the market's growth.

• Growing number of daycare procedures

Daycare procedures are those types of medical procedure or surgery that primarily requires less stay time in the hospitals. In the daycare procedure, patients must stay in the hospital for a short period. Most of the health insurance companies are now covering daycare procedures in their insurance plans, and for the claim of such types of surgery, there is no compulsion on spending 24 hours in the hospital, which is the minimum stay in the hospital claim insurance. While most health insurance plans cover hospital stays and major surgeries, the policyholders can also claim daycare procedures under their health insurance policy, which propels the demand of the market.

• Mandatory opting for health insurance in public and private sector

Buying a healthcare insurance policy is a mandatory provision for employees in the public and private sectors. Health insurance offers key medical benefits which the employee can avail of while working in a corporate. In case of any emergency or medical issues, the health insurance cover is highly useful to meet treatment expenses. The employee’s health insurance is an extended benefit the individual employer gives to their employees . The health insurance provided covers with the employee and covers their family members under the same policy plan. Also, in certain cases, the employer may pay a part of a premium or insurance coverage of the health insurance policy.

• Increasing old age population

Old age people are likely to get sicker or have health problems due to ageing and weak immune system such as dental issues, heart issues, cancer issues and terminal illness. A good senior citizen health insurance can help senior citizens to opt for good health insurance services to reduce future financial worries. Thus increasing number of old age population can boost the demand for health insurance market.

• Increasing awareness about the benefits of health insurance

In the face of a medical emergency, health insurance allows the consumers to take their mind off the stress related to healthcare costs and focus on the treatment instead with health insurance. Medical emergencies can happen at any time, regardless of our current good health or disciplined lifestyle. Therefore, it is important to plan for and protect our families and ourselves from any unforeseen medical situations, especially when there are elderly parents at home as they are more susceptible to infections or other illnesses.

Restraints/Challenges faced by the Private Health insurance Market

• High cost of premiums

Health insurance covers all types of medical treatment costs. It provides financial support to the policyholder since it covers all the medical expenses when the policyholder is hospitalized for the treatment. Health insurance also covers pre as well as post-hospitalization expenses. To purchase health insurance, the policyholder has to pay insurance premiums regularly to keep the health insurance policy active. The cost of insurance premium is high in the majority of cases based on the insurance plan, which is hampering the growth of the market.

• Lack of awareness regarding health insurance

In the field of healthcare, a large portion of the world population is still not aware of the benefits of health insurance policies. The expenses of medical care are increasing across the world with advancements made in the field. Through the advancement in technology, the healthcare sector is one of the growing segments, however, the penetration rate of health insurance policies remains low due to a lack of awareness regarding the benefits offered by them

This private health insurance market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the private health insurance market contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In March 2021, Medibank Private Limited invested $10 million in health tech company Medinet to support the growing role of virtual health in Australia – part of its strategy to drive better health outcomes by supporting more preventative and integrated care. This development will enhance the company’s image and helps to increase its business.
• In September 2021, HCF partnered with health a rail, transport and energy health fund to provide dedicated and personalized support, services and products to health employees. This development helped company to increase its business.

Australia Private Health Insurance Market Scope

The private health insurance market is segmented on the basis of type, health plan category/metal levels, provider type, age group and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

• Critical Illness Insurance
• Individual Health Insurance
• Family Health Insurance
• Disease-Specific Insurance

On the basis of type, the market is segmented into critical illness insurance, individual health insurance, family health insurance, disease-specific insurance and others.

Health Plan Category/Metal Levels

On the basis of health plan category/metal levels, the market is segmented into bronze, silver, gold platinum and others. 

  Provider Type

• Health maintenance organizations (HMOS)
• Preferred provider organizations (PPOS)
• Exclusive provider organizations (EPOS)
• Point-of-service (POS) plans
• High-deductible health plans (HDHPS)

On the basis of provider type, the market is segmented into health maintenance organizations (HMOS), preferred provider organizations (PPOS), exclusive provider organizations (EPOS), point-of-service (POS) plans, high-deductible health plans (HDHPS) and others.

• Young Adulthood (19-44 Years)
• Middle Adulthood (45-64 Years)
• Older Adulthood (65 Years And Above)

 On the basis of age group, the market is segmented into young adulthood (19-44 years), middle adulthood (45-64 years) and older adulthood (65 years and above).

Distribution Channel

• Direct Insurance Companies
• Insurance Aggregators

 On the basis of distribution channel, the market is segmented direct insurance companies, insurance aggregators and others.

Competitive Landscape and Private Health Insurance Market Share Analysis

The private health insurance market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Australia presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to private health insurance market.

Some of the major players operating in the private health insurance market are AIA Group Limited (Hong Kong), HCF (Australia), Allianz (Germany), Suncorp Group (Australia), Medibank Private Limited (Australia), HSBC Group (Hong Kong), Tokio Marine (Japan), Great Eastern Holdings Limited (Malaysia), The Royal Automobile Club of WA (Inc.). (Australia), AXA (France), Income (Australia), Aetna Inc. (A subsidiary of CVS Health), Cigna among others.

TABLE 1 NUMBER OF ADULTS HAVE PRIVATE HEALTH INSURANCE, BY AGE GROUP, MILLION, 2021

TABLE 2 NUMBER OF ADULTS HAVE PRIVATE HEALTH INSURANCE, BY INSURANCE COMPANY, MILLION, 2021

TABLE 3 NUMBER OF ADULTS HAVE PRIVATE HEALTH INSURANCE, BY PROVIDER TYPE, MILLION, 2021

TABLE 4 NEW ZEALAND PRIVATE HEALTH INSURANCE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 5 DETAILS OF AETNA INC. (A SUBSIDIARY OF CVS HEALTH) OF HEALTH MAINTENANCE ORGANIZATIONS (HMOS), BY TYPE , USD MILLION, 2021

TABLE 6 DETAILS OF AETNA INC. (A SUBSIDIARY OF CVS HEALTH) OF PREFERRED PROVIDER ORGANIZATIONS (PPOS), BY TYPE , USD MILLION, 2021

TABLE 7 DETAILS OF AETNA INC. (A SUBSIDIARY OF CVS HEALTH) OF EXCLUSIVE PROVIDER ORGANIZATIONS (EPOS), BY TYPE , USD MILLION, 2021

TABLE 8 DETAILS OF AETNA INC. (A SUBSIDIARY OF CVS HEALTH) OF POINT-OF-SERVICE (POS) PLANS, BY TYPE , USD MILLION, 2021

TABLE 9 DETAILS OF AETNA INC. (A SUBSIDIARY OF CVS HEALTH) OF HIGH-DEDUCTIBLE HEALTH PLANS (HDHPS), BY TYPE , USD MILLION, 2021

TABLE 10 DETAILS OF AETNA INC. (A SUBSIDIARY OF CVS HEALTH) OF OTHERS, BY TYPE , USD MILLION, 2021

TABLE 11 DETAILS OF CIGNA OF HEALTH MAINTENANCE ORGANIZATIONS (HMOS), BY TYPE , USD MILLION, 2021

TABLE 12 DETAILS OF CIGNA OF PREFERRED PROVIDER ORGANIZATIONS (PPOS), BY TYPE , USD MILLION, 2021

TABLE 13 DETAILS OF CIGNA OF EXCLUSIVE PROVIDER ORGANIZATIONS (EPOS), BY TYPE , USD MILLION, 2021

TABLE 14 DETAILS OF CIGNA OF POINT-OF-SERVICE (POS) PLANS, BY TYPE , USD MILLION, 2021

TABLE 15 DETAILS OF CIGNA OF HIGH-DEDUCTIBLE HEALTH PLANS (HDHPS), BY TYPE , USD MILLION, 2021

TABLE 16 DETAILS OF CIGNA OF OTHERS, BY TYPE , USD MILLION, 2021

TABLE 17 DETAILS OF AIA GROUP LIMITED OF HEALTH MAINTENANCE ORGANIZATIONS (HMOS), BY TYPE , USD MILLION, 2021

TABLE 18 DETAILS OF AIA GROUP LIMITED OF PREFERRED PROVIDER ORGANIZATIONS (PPOS), BY TYPE , USD MILLION, 2021

TABLE 19 DETAILS OF AIA GROUP LIMITED OF EXCLUSIVE PROVIDER ORGANIZATIONS (EPOS), BY TYPE , USD MILLION, 2021

TABLE 20 DETAILS OF AIA GROUP LIMITED OF POINT-OF-SERVICE (POS) PLANS, BY TYPE , USD MILLION, 2021

TABLE 21 DETAILS OF AIA GROUP LIMITED OF HIGH-DEDUCTIBLE HEALTH PLANS (HDHPS), BY TYPE , USD MILLION, 2021

TABLE 22 DETAILS OF AIA GROUP LIMITED OF OTHERS, BY TYPE , USD MILLION, 2021

TABLE 23 CHIEF MEDICAL OFFICER

TABLE 24 LIST OF DAY CARE PROCEDURES

TABLE 25 AUSTRALIA PRIVATE HEALTH INSURANCE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 26 AUSTRALIA PRIVATE HEALTH INSURANCE MARKET, BY HEALTH PLAN CATEGORY/METAL LEVELS, 2020-2029 (USD MILLION)

TABLE 27 AUSTRALIA PRIVATE HEALTH INSURANCE MARKET, BY PROVIDER TYPE, 2020-2029 (USD MILLION)

TABLE 28 AUSTRALIA PRIVATE HEALTH INSURANCE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 29 AUSTRALIA PRIVATE HEALTH INSURANCE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 30 AUSTRALIA PRIVATE HEALTH INSURANCE MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 31 AUSTRALIA PRIVATE HEALTH INSURANCE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 32 AUSTRALIA PRIVATE HEALTH INSURANCE MARKET, BY HEALTH PLAN CATEGORY/METAL LEVELS, 2020-2029 (USD MILLION)

TABLE 33 AUSTRALIA PRIVATE HEALTH INSURANCE MARKET, BY PROVIDER TYPE, 2020-2029 (USD MILLION)

TABLE 34 AUSTRALIA PRIVATE HEALTH INSURANCE MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 35 AUSTRALIA PRIVATE HEALTH INSURANCE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

Customization available:.

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

Frequently ask questions, browse related press release.

• View Infographics
• Research Methodology
• Available Customization

CHOOSE LICENCE TYPE

• Enterprise User 4200.00
• Single User 3500.00
• DBMR Factbook 2000.00
• DBMR Prime 5500.00
• DBMR Supreme 7500.00

Can be used by entire organization across the globe + Downloadable and Printable PDF + 30 + Countries

Why Choose Us

Industry coverage.

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Client Testimonials

David manning - thermo fisher scientific.

Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly. You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Manager - Market Analytics,

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Business Intelligence and Analytics,

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Competition Analyst,

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Marketing Director,

It was indeed a good experience, would definitely recommend and come back for future prospects.

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Product manager,

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Investor relations,

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Market Analyst,

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Andrew - Senior Global Marketing Manager,

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Amarildo - Manager, Global Strategic Alignment

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future

Share Your Experience With Us

Avail pdf sample reports.

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy. and Terms and Conditions

Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)

Access Current Year Market Size Data for Health Services in Australia

• Afghanistan
• Aland Islands
• American Samoa
• Antigua and Barbuda
• Bolivia, Plurinational State of
• Bonaire, Sint Eustatius and Saba
• Bosnia and Herzegovina
• Bouvet Island
• British Indian Ocean Territory
• Brunei Darussalam
• Burkina Faso
• Cayman Islands
• Central African Republic
• Christmas Island
• Cocos (Keeling) Islands
• Congo, the Democratic Republic of the
• Cook Islands
• Cote d'Ivoire
• Czech Republic
• Dominican Republic
• El Salvador
• Equatorial Guinea
• Falkland Islands (Malvinas)
• Faroe Islands
• French Guiana
• French Polynesia
• French Southern Territories
• Guinea-Bissau
• Heard Island and McDonald Islands
• Holy See (Vatican City State)
• Iran, Islamic Republic of
• Isle of Man
• Korea, Democratic People's Republic of
• Korea, Republic of
• Lao People's Democratic Republic
• Libyan Arab Jamahiriya
• Liechtenstein
• Macedonia, the former Yugoslav Republic of
• Moldova, Republic of
• Netherlands
• New Caledonia
• New Zealand
• Norfolk Island
• Palestinian Territory, Occupied
• Papua New Guinea
• Philippines
• Russian Federation
• Saint Barthélemy
• Saint Helena, Ascension and Tristan da Cunha
• Saint Kitts and Nevis
• Saint Lucia
• Saint Martin (French part)
• Saint Pierre and Miquelon
• Saint Vincent and the Grenadines
• Sao Tome and Principe
• Saudi Arabia
• Sierra Leone
• Sint Maarten (Dutch part)
• Solomon Islands
• South Africa
• South Georgia and the South Sandwich Islands
• South Sudan
• Svalbard and Jan Mayen
• Switzerland
• Syrian Arab Republic
• Tanzania, United Republic of
• Timor-Leste
• Trinidad and Tobago
• Turkmenistan
• Turks and Caicos Islands
• United Arab Emirates
• Venezuela, Bolivarian Republic of
• Virgin Islands, British
• Wallis and Futuna
• Western Sahara

Health Services in Australia - Market Size

Scroll down to view last year's statistics, or provide your details to unlock more recent data.

Provide your details to unlock more recent data.

Curious about what drives these trends ? IBISWorld's Industry Report has got you covered.

Questions Clients Ask About This Industry

Access more trends and analysis for this report.

Our analysts spend hundreds of hours poring over statistics and trends so you don’t have to.

Industry Statistics Related to this report

Number of businesses, wage statistics, employment statistics, access statistics, trends and analysis on 1,000+ global industries.

Talk to one of our reps today about how an IBISWorld Membership can make you an expert in any industry.

Trusted by More Than 10,000 Clients Around the World

Top 100 Market Research Companies in Australia

• Market Research

The Best of April 2024

Looking for a top market research company in australia.

Before you proceed with developing and marketing a new product or service, you need to make sure there is a viable market for success. The right market research company can help you with this process.  Read more +

To assist you in your search for a partner, we’ve compiled this list of the top market research agencies in Australia. Browse descriptions, feedback, and awards to find which can best suit your company’s needs.

List of the Best Australia Market Research Agencies

Featured providers

Service Excellence

Would Recommend

• Min. Project Size "> $25,000+
• Company Size "> 10 - 49 employees
• Location "> San Francisco, CA

Antedote is a strategic innovation and insight consultancy in San Francisco and London, United Kingdom. Founded in 2014, they have about 8 employees that serve enterprise and midmarket clients in a wide variety of industries. Services include business consulting and market research.

• Consumer products & services " >
• Financial services " >
• Medical " >
• Information technology " >

Eris Strategy

• Min. Project Size "> $1,000+
• Company Size "> 2 - 9 employees
• Location "> Annandale, Australia

Eris Strategy is a marketing firm founded in 2013 and based in Sydney with no more than 10 professionals. They provide market research, branding, and marketing strategy solutions to clients that work in the fields of advertising, consumer products, and financial services.

• GlaxoSmithKline
• Advertising & marketing " >
• Business services " >
• Education " >
• Government " >
• Hospitality & leisure " >
• Manufacturing " >

Get connected with a company for free

Tell us about your project, and we'll match you with vetted companies that meet your requirements.

Truly Deeply

• Min. Project Size "> $10,000+
• Location "> South Melbourne, Australia

Truly Deeply, a branding agency, was established in 1990. Based in South Melbourne, Australia, their small team specializes in branding, digital strategy, and web design.

• Arts, entertainment & music " >
• Non-profit " >
• Location "> Melbourne, Australia

Storyfolk is a branding and graphic design studio based in Collingwood, Australia. The studio, founded in 2019, has a team of less than ten that provides branding, graphic design, and web design services to small and larger-sized companies in various industries.

• Mental Health First Aid Australia
• Ethical Clothing Australia
• The Australian Government
• Energy & natural resources " >

Tiny CX Freeform

• Location "> Docklands, Australia

Tiny CX Freeform, a market research company, was founded in 2015. Their small team is headquartered in Docklands, Australia and offers market research and marketing strategy.

• Telecommunications " >
• Utilities " >

Adept Research

• Location "> Kew, Australia

Adept Research is a marketing agency founded in 1999 in Kew, Australia. With fewer than 10 members, they provide market research and marketing strategy solutions for small and mid-market firms in industries such as consumer products, advertising, and education.

• Gunnersens Pty Ltd
• Debco Pty Ltd

The Customer Experience Company

Not yet reviewed.

• Location "> Sydney, Australia
• Supply Chain, Logistics, and Transport " >

B2BLEADS.COM

• Location "> Miranda, Australia

Direct marketing company B2BLEADS.COM is headquartered in Miranda, Australia and Brisbane City, Australia. The small firm was established in 2018. Their team offers direct marketing, market research, sales outsourcing, other marketing, and more.

We Discover

• Real estate " >

Pro Digital Marketing

• Location "> Knoxfield, Australia

Pro Digital Marketing, a SEO company, is based in Knoxfield, Australia. The agency offers search engine optimization, social media marketing, pay per click, and market research and has a small team.The agency was launched in 2020.

Conjoint.ly

• Location "> Glebe, Australia

Bastion Insights

• Location "> Cremorne, Australia

Research Network

Food industry foresight.

• Min. Project Size "> $5,000+
• Location "> Harrington Park, Australia

Brand Health Pty Ltd

• Location "> West Melbourne, Australia

Lead Express

• Location "> Scoresby, Australia

Established in 2014, Lead Express is an answering service company. They are based in Scoresby, Australia and have a small team. Their services include voice services, email marketing, market research, pay per click, and more.

Inkwood Research

• Min. Project Size "> Undisclosed
• Location "> Riverside, Australia
• Location "> Abbotsford, Australia
• Automotive " >

One51 Consulting

True north research.

• Location "> Belrose, Australia

MARKETABLE STRATEGIES

Leadership empowerment pty ltd, brandmatters.

BrandMatters is a branding consultant agency based in Sydney, Australia. BrandMatters was founded in 2002 and employs a team of 14 that is exclusively dedicated to providing branding services.

• Financial Spectrum
• Location "> Collingwood, Australia

Lirata is a Collingwood, Australia-based business consulting company. The small agency was launched in 2010. Their team offers business consulting, market research, and corporate training.

Etic Consulting Group

Small branding agency Etic Consulting Group, is headquartered in Sydney, Australia. The team focuses on branding, market research, marketing strategy, and business consulting.

Cultural Perspectives

• Location "> Redfern, Australia

Cultural Perspectives is a PR firm. They are in Redfern, Australia and have a small team. Their services include public relations, market research, business consulting, and translation.

Greenroom Digital

Digital democracy pty ltd, calcul8ors pty ltd.

• Location "> Mulgrave, Australia

Get connected with the right company for you

We'll do the work for you – finding and connecting you with service providers that meet your exact requirements.

Related content

Marketing Strategy Agencies in Australia

Email Marketing Firms in Australia

SEO Content Creation Companies in Australia

Multilingual SEO Companies in Australia

Digital Marketing Companies in Australia

Local SEO Agencies in Australia

SEO Companies in Australia

Inbound Marketing Agencies in Australia

Recommended Digital Marketing Articles

How a good modal ui design can increase user engagement, top 5 seo strategies for small businesses in 2020, 5 benefits of outsourcing your social media marketing, 8 benefits of email marketing management for small business.

Australia Home Healthcare Market Analysis

The sad thing is the majority of people have no clue about what they truly want. They have no clarity. When asked the question

Australia's home healthcare market is projected to grow from $4.3 Bn in 2022 to $8.9 Bn by 2030, registering a CAGR of 9.43% during the forecast period of 2022-30. Because of the rising older population and the increasing number of people motivated to fight ailments including heart problems, diabetes, and various respiratory illnesses, the Australia home healthcare market is expanding at a promising CAGR. The market is segmented by solution, by deployment, and by end-use. There are a number of private companies that provide home healthcare services in Australia, including Bupa, NIB Health Funds, and HCF.

• Report Summary
• Table of Contents
• Segmentation
• Methodology
• Request Sample Report

Australia Home Healthcare Market Executive Summary

Australia's home healthcare market is projected to grow from $4.3 Bn in 2022 to $8.9 Bn by 2030, registering a CAGR of 9.43% during the forecast period of 2022-30.

Australia is a developed, rich nation with a robust economy that is widely diversified. It is the sixth-biggest economy in the Asia-Pacific region and the 13th-largest economy overall. Many industries, including mining, agriculture, manufacturing, and services, are the main drivers of the Australian economy. Australia's gross domestic product (GDP) was about $1.725 trillion as of 2022. In 2019–2020, Australia is expected to spend $202.5 billion on health-related goods and services, or $7,926 per person.

Australia is a substantial producer of agricultural goods like wheat, sugar, and dairy products as well as a major exporter of natural resources like coal, iron ore, and natural gas. While the services sector is the largest contributor to the economy, accounting for over 70% of GDP, the manufacturing sector is varied in the nation with a focus on high-tech and sophisticated manufacturing.

Since more people choose to get medical treatment and support in the convenience of their own homes, the home healthcare market in Australia is expanding as a part of the healthcare sector. The aging of the population, improvements in medical technology that enable more types of treatment to be provided at home, and the desire of many patients to avoid hospital stays and get care in a more familiar and comfortable environment are some of the causes driving this trend.

In Australia, home healthcare services are typically provided by a range of providers, including government agencies, non-profit organizations, and private companies. These services may include nursing care, physiotherapy, occupational therapy, speech therapy, and other types of medical and support services.

Market Dynamics

Market Growth Drivers and Restraints

Because of the rising older population and the increasing number of people motivated to fight ailments including heart problems, diabetes, and various respiratory illnesses, the Australia home healthcare market is expanding at a promising CAGR. Additionally, home healthcare equipment in Asia-Pacific is still in its infancy. These factors have been propelling home healthcare technology during the review period and will continue to do so. The Australia home healthcare market's growth would be restricted, nonetheless, by the high price in addition to the problems with payback associated with the choice of home healthcare devices. In addition, rising healthcare costs across the board are a significant driver of the Asia Pacific home healthcare market's expansion.

• Competitive Landscape

Key Players

There are a number of key players in the home healthcare market in Australia, including:

Government agencies : The federal and state governments in Australia provide a range of home healthcare services through public hospitals and community health centers. These services may include nursing care, physiotherapy, occupational therapy, and other types of medical and support services.

Non-profit organizations : There are also a number of non-profit organizations that provide home healthcare services in Australia, such as the Red Cross, Meals on Wheels, and Silver Chain Group. These organizations often rely on donations and government funding to support their services.

Private companies : There are also a number of private companies that provide home healthcare services in Australia, including

• Medibank Private
• Australian Unity
• NIB Health Funds

These companies offer a range of services, including nursing care, physiotherapy, and occupational therapy, and may also offer home modification services and assistive technology to help people live independently at home.

Individual caregivers : Many people in Australia also receive home healthcare services from individual caregivers, such as family members or private contractors. These caregivers may provide a range of services, including personal care, nursing, and home maintenance.

Healthcare Policies and Regulatory Landscape

According to the Therapeutic Goods Act 1989 (Cth) and its delegated legislation, the Therapeutic Goods Administration (TGA), the Commonwealth regulator, is responsible for overseeing the regulation of therapeutic goods in Australia, including prescription drugs, over-the-counter drugs, complementary medicines, medical devices, and certain blood and blood products. The TGA is in charge of examining, judging, and keeping track of products that are produced or supplied in, exported from, or imported into Australia.

1. Executive Summary 1.1 Service Overview 1.2 Global Scenario 1.3 Country Overview 1.4 Healthcare Scenario in Country 1.5 Healthcare Services Market in Country 1.6 Recent Developments in the Country

2. Market Size and Forecasting 2.1 Market Size (With Excel and Methodology) 2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics 3.1 Market Drivers 3.2 Market Restraints

4. Competitive Landscape 4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company 4.2.1.1 Overview 4.2.1.2 Product Applications and Services 4.2.1.3 Recent Developments 4.2.1.4 Partnerships Ecosystem 4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario 5.1 Reimbursement Regulation 5.2 Reimbursement Process for Services 5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Australia Home Healthcare Market Segmentation

By Device Type (Revenue, USD Billion):

Based on the Device Type the market is segmented into Testing, Screening, Monitoring Devices, Therapeutic Home Healthcare Devices, and Mobility Assist.

• Testing, Screening, and Monitoring Device
• Blood Glucose Monitors
• Blood Pressure Monitors
• Heart Rate Monitors
• Temperature Monitors
• Sleep Apnea Monitors
• Coagulation Monitors
• Ovulation and Pregnancy Test Kits
• Pulse Oximeters
• Home Hemoglobin A1C Test Kit
• Therapeutic Home Healthcare Devices
• Oxygen Delivery Systems
• Ventilators
• Sleep Apnea Therapeutic Devices
• Wound Care Products
• IV Equipment
• Dialysis Equipment
• Insulin Delivery Devices
• ?Other Therapeutic Products (ostomy devices, automated external defibrillators (AEDs)
• Mobility Assist
• Walkers and Rollators
• Wheelchairs
• ?Mobility Scooters

By Service Type (Revenue, USD Billion):

• Skilled Nursing Services
• Rehabilitation Therapy Services
• Hospice and Palliative Care Services
• Unskilled Care Services
• Respiratory Therapy Services
• Infusion Therapy Services
• Pregnancy Care Services?

By Indication Type (Revenue, USD Billion):

• Cardiovascular Disorders & Hypertension
• Respiratory Diseases
• Mobility Disorders
• Hearing Disorders
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

Insights10 will provide you with the reports within 10 key parameters which are:

• Market Overview
• Market Growth Drivers & Restraints
• Epidemiology of Disease Type
• Market Segmentation
• Market Share
• Key Company Profiles
• Healthcare Policies & Regulatory Framework
• Reimbursement Scenario
• Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East,  North America,  and   Latin America  for the period of 2022 to 2030 . The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

• Establishing market drivers and trends
• Analyzing the regulatory landscape to understand future growth
• Market Segment based analysis to obtain revenue/volume
• ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

• Intelligent insights to take informed business decisions
• Qualitative, acute and result oriented market analysis
• Market size and forecasts from 2022 to 2030
• Opportunities for expansion and in-depth market analysis
• Segmentation and regional revenue forecasts
• Analysis of the market share and competitive landscape
• Strategic Recommendations to chart future course of action
• Comprehensive Market Research Report in PDF and PPT formats
• Ask our analyst how this study was put together to learn more
• Discuss additional requirements as part of the free customisation
• Add more countries or regions to the scope 
• Get answers to specific business questions 
• Develop the business case to launch the product
• Find out how this report may influence your business revenue

Related reports (by category)

Netherlands Bioinformatics Market Analysis

Kenya Healthcare Insurance Market Analysis

Bulgaria Robotic Surgery Services Market Analysis

India Connected Healthcare Market Analysis

Related reports (by geography).

Australia Phenylketonuria Therapeutics Market Analysis

Australia Blockchain Technology in Healthcare Market Analysis

Australia Lysosomal Storage Disorders Drugs Market Analysis

Australia Growth Hormone Deficiency Clinical Trials Market Analysis

Kindly fill in the following details. the report will be mailed to you., subscribe to our newsletter, need assistance please fill the form.

Already have an Account? SignIn

Create an Account? SignUp

Forgot Password

Trends and Patterns in Electronic Health Record Research (1991-2022): A Bibliometric Analysis of Australian Literature

Affiliations.

• 1 College of Business Government and Law, Flinders University, Adelaide, SA 5042, Australia.
• 2 Australian Industrial Transformation Institute, College of Business Government and Law, Flinders University, Adelaide, SA 5042, Australia.
• 3 Menzies Centre for Health Policy and Economics, School of Public Health, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2050, Australia.
• PMID: 38541361
• PMCID: PMC10970652
• DOI: 10.3390/ijerph21030361

Electronic Heath Records (EHRs) play vital roles in facilitating streamlined service provision and governance across the Australian health system. Given the recent challenges due to the COVID-19 pandemic, an ageing population, health workforce silos, and growing inefficiencies in traditional systems, a detailed historical analysis of the use of EHR research in Australia is necessary. The aim of this study is to examine the trends and patterns in EHR research in Australia over the past three decades by employing bibliometric methods. A total of 951 articles published in 443 sources were included in the bibliometric analysis. The annual growth rate of EHR research in Australia was about 17.1%. Since 2022, the main trending topics in EHR research were COVID-19, opioid usage, and natural language processing. A thematic analysis indicated aged care, clinical decision support systems, cardiovascular disease, drug allergy, and adverse drug reaction as the "hot" themes in EHR research in Australia. This study reveals a significant uptrend in EHR research in Australia, highlighting the evolving intellectual and collaborative landscape of this interdisciplinary field. The data also provide guidance for policymakers and funding institutions in terms of the most significant contributions and key fields of research while also holding public interest.

Keywords: Australia; bibliometric analysis; electronic health record; electronic medical record.

• Australia / epidemiology
• Bibliometrics
• Electronic Health Records*
• Publications

Grants and funding